Peter Barany

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: PEDIATRIC NEPHROLOGY. 2026;:1-12
Neuron-specific enolase and brain-derived neurotrophic factor as developmental neurovascular markers in chronic kidney disease and kidney transplantation
Hernandez L; Strizzi CT; Lindblad YT; Stenvinkel P; Barany P; Chromek M; Kublickiene K
Article: CLINICAL KIDNEY JOURNAL. 2026;19(5):sfag075
Erythroferrone is associated with the hepcidin-to-ferritin ratio and cardiovascular mortality in chronic kidney disease
Pistis KD; Qureshi AR; Beshara S; Lindholm B; Stenvinkel P; Barany P
Article: SCIENTIFIC REPORTS. 2026;16(1):11603
Low Fischer's ratio is associated with increased mortality in patients with kidney failure
Zhang Q; Suliman ME; Qureshi AR; Guo F; Troise D; Xu R; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Journal article: KIDNEY INTERNATIONAL REPORTS. 2026;11(4):104224
WCN26-4310 ASSOCIATION OF ATHEROGENIC INDEX OF PLASMA WITH MORTALITY IN END-STAGE RENAL DISEASE PATIENTS: A CROSS-COUNTRY COMPARATIVE ANALYSIS
Chen Z; Qureshi AR; Ryu K; Suliman ME; Barany P; Heimburger O; Stenvinkel P; Han F; Jiang H; Chen J; Wang R; Lindholm B
Journal article: KIDNEY INTERNATIONAL REPORTS. 2026;11(4):104213
WCN26-3593 PLASMA BRANCHED-CHAIN AMINO ACIDS IN CHRONIC KIDNEY DISEASE: ASSOCIATIONS WITH ATHEROGENIC LIPIDS AND MORTALITY
Suliman ME; Qureshi ARQ; Troise D; Zhang Q-Y; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: AMINO ACIDS. 2026;58(1):20
Plasma branched-chain amino acids in chronic kidney disease: associations with atherogenic lipids and mortality
Suliman ME; Qureshi AR; Troise D; Zhang Q; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: JOURNAL OF CELL COMMUNICATION AND SIGNALING. 2026;20(1):e70061
The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease
Moor MB; Burmakin M; Levin A; Korkut GG; Brodin D; Wernerson A; Bruchfeld A; Barany P; Witasp A; Patrakka J; Olauson H
Article: KIDNEY INTERNATIONAL. 2026;109(2):379-389
A national cohort study examined the risk of severe infection and infection-related mortality in patients with chronic kidney disease with lupus nephritis in comparison to other chronic kidney disease etiologies
Chrysostomou C; Faustini F; Segelmark M; Carrero J-JS; Gunnarsson I; Barany P; Evans M; Faucon A-L
Article: TOXINS. 2025;17(12):592
Correlations Between Trimethylamine-N-Oxide, Megalin, Lysine and Markers of Tubular Damage in Chronic Kidney Disease
Kapetanaki S; Salihovic S; Kumawat AK; Massy ZA; Persson K; Barany P; Stenvinkel P; Evans M; Demirel I
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025;36(12):2392-2409
Transcriptomic Patterns in Adult and Pediatric Patients with IgA Nephropathy or IgA Vasculitis with Nephropathy
Levin A; Schwarz A; van Hoef V; Wijkstrom J; Bruchfeld A; Herthelius M; Wennberg L; Barany P; Witasp A; Wernerson A
Article: CLINICAL KIDNEY JOURNAL. 2025;18(11):sfaf296
Applicability of the Framingham Risk Score in predicting mortality among kidney failure patients: an international analysis
Chen Z; Li X; Qureshi AR; Wang R; Jiang H; Heimburger O; Barany P; Chen J; Stenvinkel P; Lindholm B
Article: JOURNAL OF CLINICAL MEDICINE. 2025;14(21):7577
Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney Disease
Jankowska M; Qureshi AR; Haarhaus M; Magnusson P; Debska-Slizien A; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: SCIENTIFIC REPORTS. 2025;15(1):2645
Association between extracellular DNA levels, markers of inflammation and left ventricular mass index in children with chronic kidney disease
Lindblad YT; Tothova L; Celec P; Kublickiene K; Barany P; Chromek M
Article: KIDNEY INTERNATIONAL REPORTS. 2025;10(1):157-168
Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies
Chrysostomou C; Faustini F; Gunnarsson I; Segelmark M; Carrero J-J; Barany P; Faucon A-L; Evans M
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2025;85(1):45-54.e1
Burden of CKD-Associated Pruritus and Adverse Clinical Outcomes in Patients Receiving Dialysis: The Stockholm Creatinine Measurements (SCREAM) Project
Faucon A-L; Clase CM; Rydell H; Uhde M; Barany P; Evans M; Carrero J-J
Article: NUTRITION. 2024;125:112470
Handgrip strength and mortality in a cohort of kidney failure patients: Comparative analysis of different normalization methods
Suliman ME; Ryu K; Qureshi AR; Li X; Avesani CM; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: ESC HEART FAILURE. 2024;11(4):2334-2343
Heart failure: the grim reaper of the cardio-renal-metabolic triad
Osterman J; Al-Sodany E; Lofman IH; Barany P; Evans M
Article: LAKARTIDNINGEN. 2024;121:23214
SGLT2-hämmare – bra för hjärta och njurar men tänk på riskerna.
Nowinski K; Ugarph-Morawski A; Bárány P; Curman P
Article: CELLS. 2023;12(24):2774
Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation
Leotta C; Hernandez L; Tothova L; Arefin S; Ciceri P; Cozzolino MG; Barany P; Chromek M; Stenvinkel P; Kublickiene K
Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(5):628-639
Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care
Xu Y; Evans M; Mazhar F; Arnlov J; Cockburn E; Barany P; Carrero J-J
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2023;82(5):534-542
Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice
Carrero J-J; Fu EL; Sang Y; Ballew S; Evans M; Elinder C-G; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2023;34(7):1241-1251
Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations
Fu EL; Levey AS; Coresh J; Elinder C-G; Rotmans JI; Dekker FW; Paik JM; Barany P; Grams ME; Inker LA; Carrero J-J
Article: JOURNAL OF NEPHROLOGY. 2023;36(3):705-711
Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
Alkas J; Bosi A; Sjolander A; Barany P; Elinder C-G; Fu EL; Carrero JJ
Article: PEDIATRIC NEPHROLOGY. 2023;38(4):1205-1214
Kidney outcomes in early adolescence following perinatal asphyxia and hypothermia-treated hypoxic-ischaemic encephalopathy
Grossmann KR; Vishnevskaya L; Ruiz SD; Kublickiene K; Barany P; Blennow M; Chromek M
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(7):6628
Blood-Brain Barrier Biomarkers before and after Kidney Transplantation
Hernandez L; Ward LJ; Arefin S; Barany P; Wennberg L; Soderberg M; Bruno S; Cantaluppi V; Stenvinkel P; Kublickiene K
Article: FRONTIERS IN NUTRITION. 2023;10:1035343
Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
Ryu K; Suliman ME; Qureshi AR; Chen Z; Avesani CM; Brismar TB; Ripsweden J; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: JOURNAL OF RENAL NUTRITION. 2023;33(2):298-306
Low-Plasma Insulin-Like Growth Factor-1 Associates With Increased Mortality in Chronic Kidney Disease Patients With Reduced Muscle Strength
Chen Z; Nilsson E; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR; Chen J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023;38(2):311-321
The role of dendrin in IgA nephropathy
Levin A; Schwarz A; Hulkko J; He L; Sun Y; Barany P; Bruchfeld A; Herthelius M; Wennberg L; Ebefors K; Patrakka J; Betsholtz C; Nystrom J; Molne J; Hultenby K; Witasp A; Wernerson A
Article: BMC NEPHROLOGY. 2023;24(1):20
The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease
Pistis KD; Westerberg P-A; Qureshi AR; Beshara S; Sterner G; Barany P; Linde T
Article: FRONTIERS IN ENDOCRINOLOGY. 2023;13:1046392
Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease
Grigore TVV; Zuidscherwoude M; Witasp A; Barany P; Wernerson A; Bruchfeld A; Xu H; Olauson H; Hoenderop J
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2023;54(7-8):268-274
Interleukin-6 to albumin ratio as a superior predictor of mortality in end stage kidney disease patients
Li X; Qureshi AR; Suliman ME; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: PEDIATRIC NEPHROLOGY. 2022;37(12):3165-3175
Cardiac biomarkers in pediatric CKD-a prospective follow-up study
Lindblad YT; Vavilis G; Chromek M; Quershi AR; Lowbeer C; Barany P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(12):2474-2486
Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study
Verploegen MFA; Vargas-Poussou R; Walsh SB; Alpay H; Amouzegar A; Ariceta G; Atmis B; Bacchetta J; Barany P; Baron S; Bayrakci US; Belge H; Besouw M; Blanchard A; Bokenkamp A; Boyer O; Burgmaier K; Calo LA; Decramer S; Devuyst O; van Dyck M; Ferraro PM; Fila M; Francisco T; Ghiggeri GM; Gondra L; Guarino S; Hooman N; Hoorn EJ; Houillier P; Kamperis K; Kari JA; Konrad M; Levtchenko E; Lucchetti L; Lugani F; Marzuillo P; Mohidin B; Neuhaus TJ; Osman A; Papizh S; Perello M; Rookmaaker MB; Conti VS; Santos F; Sawaf G; Serdaroglu E; Szczepanska M; Taroni F; Topaloglu R; Trepiccione F; Vidal E; Wan ER; Weber L; Yildirim ZY; Yuksel S; Zlatanova G; Bockenhauer D; Emma F; Nijenhuis T
Article: LAKARTIDNINGEN. 2022;119:22017
[Janusmed Renal Function, an appreciated CDSS to support prescription of drugs and appropriate dosing in patients with renal impairment].
Justad H; Askfors Y; Shemeikka T; Rosenborg S; Veg A; Bárány P; Elinder C-G
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11S):231
Blood-Brain-Barrier Biomarkers in Patients Before and After Kidney Transplantation
Hernandez LN; Ward LJ; Arefin S; Barany PF
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11S):246-247
Burden of Anemia in Patients With CKD Stages 3-5 Managed in Primary Care
Evans M; Xu Y; Mazhar F; Arnlov J; Cockburn E; Barany PF; Carrero JJ
Article: JOURNAL OF HYPERTENSION. 2022;40(8):1487-1498
Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study
Al-Sodany E; Chesnaye NC; Heimburger O; Jager KJ; Barany P; Evans M
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2022;52(8):e13786
Angiotensin-converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end-stage kidney disease
Arefin S; Hernandez L; Ward LJ; Schwarz A; Barany P; Stenvinkel P; Kublickiene K
Article: SCIENTIFIC REPORTS. 2022;12(1):4414
Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
Hernandez L; Ward LJ; Arefin S; Ebert T; Laucyte-Cibulskiene A; Heimburger O; Barany P; Wennberg L; Stenvinkel P; Kublickiene K
Article: CLINICAL KIDNEY JOURNAL. 2022;15(3):442-451
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care
Bosi A; Xu Y; Gasparini A; Wettermark B; Barany P; Bellocco R; Inker LA; Chang AR; McAdams-DeMarco M; Grams ME; Shin J-I; Carrero JJ
Article: JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022;79(4):327-336
Association of Longitudinal High-Sensitivity Troponin T With Mortality in Patients With Chronic Kidney Disease
Chesnaye NC; Al-Sodany E; Szummer K; Barany P; Heimburger O; Almquist T; Melander S; Uhlin F; Dekker F; Wanner C; Jager KJ; Evans M
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2022;163:58-64
Epidemiology of Aortic Stenosis/Aortic Valve Replacement (from the Nationwide Swedish Renal Registry)
Vavilis G; Back M; Barany P; Szummer K
Article: SCIENTIFIC REPORTS. 2022;12(1):470
Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy
Witasp A; Luttropp K; Qureshi AR; Barany P; Heimburger O; Wennberg L; Ekstrom TJ; Shiels PG; Stenvinkel P; Nordfors L
Article: ACTA PAEDIATRICA. 2022;111(1):86-92
Acute kidney injury in infants with hypothermia-treated hypoxic-ischaemic encephalopathy: An observational population-based study
Grossmann KR; Barany P; Blennow M; Chromek M
Article: LAKARTIDNINGEN. 2021;118:21096
SGLT2-hämmare minskar risk för hjärt–kärl- och njursjukdom.
Nowinski K; Mannheimer B; Bárány P
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(10S):188
Serum Erythroferrone and Serum Hepcidin 25 Are Associated with CKD
Pistis KD; Qureshi ART; Stenvinkel P; Lindholm B; Barany PF
Article: CLINICAL KIDNEY JOURNAL. 2021;14(10):2213-2220
Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease
Xu Y; Evans M; Soro M; Barany P; Carrero JJ
Article: CLINICAL KIDNEY JOURNAL. 2021;14(7):1789-1797
High-sensitivity troponins in dialysis patients: variation and prognostic value
Snaedal S; Barany P; Lund SH; Qureshi AR; Heimburger O; Stenvinkel P; Lowbeer C; Szummer K
Article: CLINICAL KIDNEY JOURNAL. 2021;14(7):1780-1788
Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study
Xu Y; Evans M; Barany P; James G; Sjolander A; Carrero JJ
Article: JOURNAL OF BONE AND MINERAL METABOLISM. 2021;39(2):260-269
Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality
Iseri K; Qureshi AR; Ripsweden J; Heimburger O; Barany P; Bergstrom IB; Stenvinkel P; Brismar TB; Lindholm B
Article: PLOS ONE. 2021;16(2):e0247623
Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study
Dai L; Li L; Erlandsson H; Jaminon AMG; Qureshi AR; Ripsweden J; Brismar TB; Witasp A; Heimburger O; Jorgensen HS; Barany P; Lindholm B; Evenepoel P; Schurgers LJ; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(12):2059-2072
Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium
Levin A; Reznichenko A; Witasp A; Liu P; Greasley PJ; Sorrentino A; Blondal T; Zambrano S; Nordstrom J; Bruchfeld A; Barany P; Ebefors K; Erlandsson F; Patrakka J; Stenvinkel P; Nystrom J; Wernerson A
Journal article: CIRCULATION. 2020;142
Risk Factors for New-onset Aortic Stenosis and Aortic Valve Replacement in End-Stage Renal Disease Patients - Results From the Swedish Renal Registry
Vavilis G; Back M; Barany P; Szummer K
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(11):1908-1915
Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project
Runesson B; Trevisan M; Iseri K; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ
Article: CLINICAL KIDNEY JOURNAL. 2020;13(5):821-827
Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
Evans M; Bower H; Cockburn E; Jacobson SH; Barany P; Carrero J-J
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2020;31(10S):362
Poor Vitamin K Status Associates with Worse Clinical Outcome Independent of Coronary Artery Calcium and Aortic Valve Calcium in ESRD
Dai L; Li L; Qureshi ART; Ripsweden J; Brismar TB; Heimburger O; Barany PF; Lindholm B; Schurgers LJ; Stenvinkel P
Article: CLINICAL TRANSPLANTATION. 2020;34(10):e14063
Pediatric transplantation in Europe during the COVID-19 pandemic: Early impact on activity and healthcare
Dona D; Torres Canizales J; Benetti E; Cananzi M; De Corti F; Calore E; Hierro L; Ramos Boluda E; Melgosa Hijosa M; Garcia Guereta L; Perez Martinez A; Barrios M; Costa Reis P; Teixeira A; Lopes MF; Kalicinski P; Branchereau S; Boyer O; Debray D; Sciveres M; Wennberg L; Fischler B; Barany P; Baker A; Baumann U; Schwerk N; Nicastro E; Candusso M; Toporski J; Sokal E; Stephenne X; Lindemans C; Miglinas M; Rascon J; Jara P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(9):1518-1526
Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study
Laureati P; Xu Y; Trevisan M; Schalin L; Mariani I; Bellocco R; Sood MM; Barany P; Sjolander A; Evans M; Carrero JJ
Article: DIABETES OBESITY & METABOLISM. 2020;22(8):1425-1435
Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm Creatinine Measurements (SCREAM) project
Runesson B; Xu Y; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(7):1202-1211
Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease
Mukai H; Dai L; Chen Z; Lindholm B; Ripsweden J; Brismar TB; Heimburger O; Barany P; Qureshi AR; Soderberg M; Back M; Stenvinkel P
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(4):422-434
Phenotypic features of vascular calcification in chronic kidney disease
Dai L; Debowska M; Lukaszuk T; Bobrowski L; Barany P; Soderberg M; Thiagarajan D; Frostegard J; Wennberg L; Lindholm B; Qureshi AR; Waniewski J; Stenvinkel P
Article: BMC NEPHROLOGY. 2020;21(1):43
Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5.
Golembiewska E; Qureshi AR; Dai L; Lindholm B; Heimbürger O; Söderberg M; Brismar TB; Ripsweden J; Barany P; Johnson RJ; Stenvinkel P
Article: BONE. 2020;130:115075
Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study
Iseri K; Qureshi AR; Dai L; Ripsweden J; Heimburger O; Barany P; Bergstrom I; Stenvinkel P; Brismar TB; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(12):2051-2057
Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease
Xu H; Hashem A; Witasp A; Mencke R; Goldsmith D; Barany P; Bruchfeld A; Wernerson A; Carrero J-J; Olauson H
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(21):e013091
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
Chesnaye NC; Szummer K; Barany P; Heimburger O; Magin H; Almquist T; Uhlin F; Dekker FW; Wanner C; Jager KJ; Evans M; Cupisti A; Sagliocca A; Ferraro A; Musiala A; Mele A; Naticchia A; Cosaro A; Woodman A; Ranghino A; Stucchi A; Jonsson A; Schneider A; Pignataro A; Schrander A; Torp A; McKeever A; Szymczak A; Blom A-L; De Blasio A; Pani A; Tsalouichos A; Ullah A; McLaren B; van Dam B; Iwig B; Antonio B; Di Iorio BR; Rogland B; Perras B; Alessandra B; Harron C; Wallquist C; Siegert C; Barrett C; Gaillard C; Abaterusso C; Beerenhout C; O'Toole C; Somma C; Marx C; Drechsler C; Summersgill C; Blaser C; D'alessandro C; Emde C; Torino C; Zullo C; Pozzi C; Geddes C; Verburgh C; Janmaat C; Bergamo D; Ciurlino D; Motta D; Glowski D; McGlynn D; Vargas D; Krieter D; Russo D; Fuchs D; Sands D; Hoogeveen E; Irmler E; Dimeny E; Favaro E; Platen E; Olczyk E; Hoorn E; Vigotti F; Caskey F; Ansali F; Conte F; Cianciotta F; Giacchino F; Cappellaio F; Pizzarelli F; Sundelin F; Greco G; Roy G; Porto G; Bigatti G; Marinangeli G; Cabiddu G; Hirst G; Fumagalli G; Caloro G; Piccoli G; Capasso G; Gambaro G; Tognarelli G; Bonforte G; Conte G; Toscano G; Del Rosso G; Welander G; Augustyniak-Bartosik H; Boots J; Schmidt-Gurtler H; King H; McNally H; Schlee H; Boom H; Naujoks H; Masri-Senghor H; Murtagh H; Rayner H; Miskowiec-Wisniewska I; Schlee I; Capizzi I; Casar S; Hernandez IB; Baragetti I; Manitius J; Turner J; Eijgenraam J-W; Kooman J; Beige J; Pondel J; Wilcox J; Berdeprado J; Rothele J; Wong J; Rotmans J; Banda J; Mazur J; Hahn K; Jezdrzejak K; Nowanska K; Blouin K; Neumeier K; Jones K; Anding-Rost K; Grontoft K-C; Oldrizzi L; Haydock L; Vogt L; Wilkinson L; Gesualdo L; Schramm L; Biancone L; Nowak L; Raasveld M; Szymczak M; Durlik M; Magnano M; Vervloet M; Ricardi M; Carmody M; Di Bari M; Laudato M; Sirico ML; Stendahl M; Svensson M; Weetman M; van Buren M; Joinson M; Ferraresi M; Dutton M; Postorino M; van Diepen M; Matthews M; Provenzano M; Hopf M; Malaguti M; Wuttke N; Morgan N; Palmieri N; Frischmuth N; Bleakley N; Murrone P; Cockwell P; Leurs P; Roderick P; Voskamp P; Kashioulis P; Ichtiaris P; Blankestijn P; Kirste P; Schulz P; Mason P; Kalra P; Cirillo P; Dattolo P; Acampora P; Sajith R; Nigro R; Boero R; Scarpioni R; Sicoli R; Malandra R; Aign S; van Esch S; Chapman S; Biribauer S; Navjee S; Crosbie S; Brown S; Tickle S; Manan S; Roser S; Savoldi S; Bertoli S; Borrelli S; Boorsma S; Heidenreich S; Melander S; Maxia S; Maffei S; Mangano S; Palm S; Konings C; Mathavakkannan S; Schwedler S; Delrieux S; Renker S; Schattel S; Dorota S; Cicchetti T; Nieszporek T; Stephan T; Schmiedeke T; Weinreich T; Leimbach T; Rappa T; Stovesand T; Bahner U; Jensen U; Palazzo V; De Simone W; Seeger W; Kuan Y; Heleniak Z; Aydin Z
Article: AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. 2019;317(5):F1122-F1131
Reduced skeletal muscle expression of mitochondrial-derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease
Liu C; Gidlund E-K; Witasp A; Qureshi AR; Soderberg M; Thorell A; Nader GA; Barany P; Stenvinkel P; von Walden F
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2019;68:60-65
Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease
Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimburger O; Barany P; Lindholm B; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(9):1534-1541
Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project
Gasparini A; Evans M; Barany P; Xu H; Jernberg T; Arnlov J; Lund LH; Carrero J-J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp411
FP411THE ASSOCIATION BETWEEN RENAL FUNCTION AND TROPONIN T OVER TIME IN STABLE CKD PATIENTS
Chesnaye N; Szummer K; Barany P; Heimburger O; Magin H; Uhlin F; Dekker FW; Wanner C; Jager K; Evans M
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp151
FP151SODIUM POLYSTYRENE SULFONATE, PRACTICE PATTERNS AND ASSOCIATED ADVERSE EVENT RISK; A NATIONWIDE ANALYSIS FROM THE SWEDISH RENAL REGISTER
Laureati P; Evans M; Trevisan M; Schalin L; Bellocco R; Sood MM; Barany P; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp361
FP361PREDICTORS OF VASCULAR CALCIFICATION IN END-STAGE RENAL DISEASE PATIENTS
Dai L; Debowska M; Lukaszuk T; Bobrowski L; Pietribiasi M; Barany P; Söderberg M; Wernerson A; Lindholm B; Qureshi AR; Waniewski J; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz096.fc020
FC020BONE MINERAL DENSITY AT VARIOUS SITES VERSUS MORTALITY IN END-STAGE RENAL DISEASE (ESRD)
Iseri K; Qureshi AR; Dai L; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz103.sp402
SP402PENTOSIDINE IN END-STAGE RENAL DISEASE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) VERSUS OTHER ETIOLOGIES
Jankowska M; Qureshi AR; Lu D; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp392
FP392DYNAMIC PREDICTION OF MORTALITY IN ADVANCED CKD USING TROPONIN T
Chesnaye N; Szummer K; Barany P; Heimburger O; Stenvinkel P; Melander S; Dekker FW; Wanner C; Jager K; Evans M
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp391
FP391FRACTURE RISK IN NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (CKD): INCIDENCE, PREDICTORS AND SEQUELAE
Runesson B; Trevisan M; Iseri K; Bengt L; Peter B; Elinder C-G; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz096.fo040
FO040Achieved blood pressure and outcomes in patients with advanced chronic kidney disease stage 4-5
Al-sodany E; Marie E; Olof H; Peter B
Article: BMC NEPHROLOGY. 2019;20(1):144
Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
Pei M; Aguiar R; Pagels AA; Heimburger O; Stenvinkel P; Barany P; Medin C; Jacobson SH; Hylander B; Lindholm B; Qureshi AR
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(8):e010546
Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
Mok Y; Ballew SH; Sang Y; Grams ME; Coresh J; Evans M; Barany P; Arnlov J; Carrero J-J; Matsushita K
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2019;14(4):530-539
Estimated Glomerular Filtration Rate and the Risk of Cancer
Xu H; Matsushita K; Su G; Trevisan M; Arnlov J; Barany P; Lindholm B; Elinder C-G; Lambe M; Carrero J-J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(3):442-448
Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study
Mukai H; Svedberg O; Lindholm B; Dai L; Heimbuerger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Article: BMC NEPHROLOGY. 2019;20(1):59
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
Chen Z; Qureshi AR; Brismar TB; Ripsweden J; Haarhaus M; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Article: JOURNAL OF NEPHROLOGY. 2019;32(1):111-119
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.
Feldreich T; Nowak C; Fall T; Carlsson AC; Carrero J-J; Ripsweden J; Qureshi AR; Heimbürger O; Barany P; Stenvinkel P; Vuilleumier N; Kalra PA; Green D; Ärnlöv J
Article: PLOS ONE. 2019;14(1):e0209440
Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project
Runesson B; Qureshi AR; Xu H; Gasparini A; Lindholm B; Barany P; Elinder CG; Carrero JJ
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2018;13(9):1314-1320
Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease The Stockholm CREAtinine Measurements (SCREAM) Project
Carrero JJ; Trevisan M; Sood MM; Barany P; Xu H; Evans M; Friberg L; Szummer K
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2018;20(8):1217-1226
Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists
Trevisan M; de Deco P; Xu H; Evans M; Lindholm B; Bellocco R; Barany P; Jernberg T; Lund LH; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i455
SP330AEGFR AND THE RISK OF CANCER: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Xu H; Su G; Trevisan M; Elinder C-G; Barany P; Lindholm B; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i146
FP341PLASMA POTASSIUM AND THE RISK OF MORTALITY: A TIME-DEPENDENT ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Trevisan M; Evans M; Xu H; Lindholm B; Barany P; Elinder C-G; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i1
FO002FIBROBLAST GROWTH FACTOR 23 IS ASSOCIATED WITH FRACTIONAL SODIUM EXCRETION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Xu H; Hashem A; Witasp A; Mencke R; Stenvinkel P; Barany P; Bruchfeld A; Wernerson A; Carrero J-J; Olauson H
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i144-i145
FP336HIGHER NEUTROPHIL TO LYMPHOCYTE RATIO ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS
Mukai H; Kato S; Lindholm B; Heimbürger O; Barany P; Washida N; Stenvinkel P; Qureshi AR
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i325
SaO024INCIDENCE, PREDICTORS AND CLINICAL MANAGEMENT OF HYPERKALEMIA IN NEW USERS OF MINERALOCORTICOID RECEPTOR ANTAGONISTS
Trevisan M; de Deco P; Xu H; Evans M; Lindholm B; Bellocco R; Barany P; Jernberg T; Lund L; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i452
SP323HIGH FIBRINOGEN LEVELS ARE INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
Hasbal NB; Mukai H; Chen Z; Lindholm B; Heimbürger O; Barany P; Stenvinkel P; Qureshi AR
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i444
SP298HIGHER MEAN CORPUSCULAR VOLUME ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS
Mukai H; Lindholm B; Heimbürger O; Barany P; Qureshi AR; Stenvinkel P
Article: EUROPEAN HEART JOURNAL. 2018;39(17):1535-1542
Serumpotassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortiummeta-analysis
Kovesdy CP; Matsushita K; Sang Y; Brunskill NJ; Carrero JJ; Chodick G; Hasegawa T; Heerspink HL; Hirayama A; Landman GWD; Levin A; Nitsch D; Wheeler DC; Coresh J; Hallan SI; Shalev V; Grams ME
Article: PLOS ONE. 2018;13(4):e0195585
Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease
Mukai H; Ming P; Lindholm B; Heimburger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Article: SCIENTIFIC REPORTS. 2018;8(1):5148
Lower serum calcium is independently associated with CKD progression
Janmaat CJ; van Diepen M; Gasparini A; Evans M; Qureshi AR; Arnlov J; Barany P; Elinder C-G; Rotmans JI; Vervloet M; Dekker FW; Carrero JJ
Article: SCIENTIFIC REPORTS. 2018;8(1):2103
Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism
Evans M; Methven S; Gasparini A; Barany P; Birnie K; MacNeill S; May MT; Caskey FJ; Carrero J-J
Article: PLOS ONE. 2018;13(1):e0190410
The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
Alves FC; Sun J; Qureshi AR; Dai L; Snaedal S; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Article: KIDNEY & BLOOD PRESSURE RESEARCH. 2018;43(2):522-535
Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
Mukai H; Ming P; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR
Article: NEPHROLOGY. 2018;23(1):31-36
Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?
Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: NEPHRON. 2018;140(4):249-256
Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study
Levin A; Nair D; Qureshi AR; Barany P; Heimburger O; Anderstam B; Stenvinkel P; Bruchfeld A; Ungerstedt JS
Article: PEDIATRIC NEPHROLOGY. 2018;33(1):147-157
The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study
Lindblad YT; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Barany P
Article: PLOS ONE. 2017;12(12):e0186659
Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients
Dai L; Mukai H; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(11):1892-1901
Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients
Evans M; Carrero J-J; Bellocco R; Barany P; Qureshi AR; Seeberger A; Jacobson SH; Hylander-Rossner B; Rotnitzky A; Sjolander A
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2017;12(9):1399-1408
eGFR and the Risk of Community-Acquired Infections
Xu H; Gasparini A; Ishigami J; Mzayen K; Su G; Barany P; Arnlov J; Lindholm B; Elinder CG; Matsushita K; Carrero JJ
Article: JOURNAL OF BONE AND MINERAL METABOLISM. 2017;35(5):536-543
Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients
Chen Z; Sun J; Haarhaus M; Barany P; Wennberg L; Ripsweden J; Brismar TB; Lindholm B; Wernerson A; Soderberg M; Stenvinkel P; Qureshi AR
Article: LANCET DIABETES & ENDOCRINOLOGY. 2017;5(9):718-728
Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
Matsushita K; Ballew SH; Coresh J; Arima H; Arnlov J; Cirillo M; Ebert N; Hiramoto JS; Kimm H; Shlipak MG; Visseren FLJ; Gansevoort RT; Kovesdy CP; Shalev V; Woodward M; Kronenberg F
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx504.p4598
P4598Incident atrial fibrillation and the risk of stroke in patients with chronic kidney disease
Szummer K; Trevisan M; Barany P; Xu H; Evans M; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii569-iii570
MP386KIDNEY FUNCTION AND THE RISK OF COMMUNITY ACQUIRED INFECTIONS
Xu H; Gasparini A; Ishigami J; Mzayen K; Su G; Barany P; Ärnlöv J; Lindholm B; Elinder CG; Matsushita K; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii586
MP429SUBJECTIVE GLOBAL ASSESSMENT OF NUTRITIONAL STATUS AS PREDICTOR OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS
Dai L; Mukai H; Lindholm B; Heimbürger O; Barany P; Stenvinkel P; Qureshi A
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii56-iii57
MO035INFLAMMATION MODIFIES THE MORTALITY PREDICTIVE CAPACITY OF OXIDATIVE DNA DAMAGE IN CHRONIC KIDNEY DISEASE PATIENTS
Dai L; Qureshi A; Mukai H; Machowska A; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii173
SP205CAUSES OF DEATH ACROSS REDUCED KIDNEY FUNCTION; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Runesson B; Qureshi A; Gasparini A; Barany P; Evans M; Elinder C-G; Wettermark B; Carrero J-J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii13
SO020INAPPROPRIATE PRESCRIPTION OF NEPHROTOXIC DRUGS TO INDIVIDUALS WITH CHRONIC KIDNEY DISEASE: A COMMUNITY-BASED ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Gasparini A; Wettermark B; Schmidt-Mende K; Evans M; Qureshi AR; Barany P; Elinder C-G; Carrero J-J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii88
TO024COMBINATION OF GENOTYPE AND PHENOTYPE FEATURES AS PREDICTORS OF INFLAMMATION, CARDIOVASCULAR DISEASE AND PROTEIN ENERGY WASTING IN PATIENTS WITH CHRONIC KIDNEY DISEASES
Debowska M; Lukaszuk T; Nordfors L; Carrero JJ; Qureshi AR; Stenvinkel P; Heimburger O; Barany P; Bobrowski L; Schalling M; Lindholm B; Waniewski J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii227-iii228
SP349IMPACT OF CINACALCET TREATMENT ON CARDIOVASCULAR OUTCOMES IN CKD PATIENTS WITH SECONDARY HYPERPARATHYROIDISM; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Evans M; Methven S; Sjolander A; May M; MacNeill S; Birnie K; Barany P; Carrero J-J; Caskey F
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii590
MP440OBSTRUCTIVE AND RESTRICTIVE LUNG FUNCTION ASSOCIATES WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Mukai H; Ming P; Lindholm B; Heimbürger O; Barany P; Stenvinkel P; Qureshi A
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii34
SO059CIRCULATING PROTEINS AS PREDICTORS OF CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS - A PROTEOMIC APPROACH
Feldreich T; Fall T; Carlsson A; Jesus-Carrero J; Qureshi A; Heimburger O; Barany P; Stenvinkel P; Arnlov J
Article: JOURNAL OF NEPHROLOGY. 2017;30(2):255-262
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis
Bergman A; Qureshi AR; Haarhaus M; Lindholm B; Barany P; Heimburger O; Stenvinkel P; Anderstam B
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2017;6(3):e004925
Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction
Szummer K; Gasparini A; Eliasson S; Arnlov J; Qureshi AR; Barany P; Evans M; Friberg L; Carrero JJ
Article: AGING-US. 2017;9(2):494-507
CDKN2A/p16INK4^α expression is associated with vascular progeria in chronic kidney disease
Stenvinkel P; Luttropp K; McGuinness D; Witasp A; Qureshi AR; Wernerson A; Nordfors L; Schalling M; Ripsweden J; Wennberg L; Soderberg M; Barany P; Olauson H; Shiels PG
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2017;47(2):137-148
Does statins promote vascular calcification in chronic kidney disease?
Chen Z; Qureshi AR; Parini P; Hurt-Camejo E; Ripsweden J; Brismar TB; Barany P; Jaminon AM; Schurgers LJ; Heimburger O; Lindholm B; Stenvinkel P
Article: KIDNEY & BLOOD PRESSURE RESEARCH. 2017;42(5):877-885
Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time
Van Craenenbroeck AH; Bragfors-Helin A-C; Qureshi AR; Lindholm B; Sjoberg B; Anderstam B; Heimburger O; Stenvinkel P; Barany P
Article: KIDNEY INTERNATIONAL. 2017;91(1):244-251
Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
Carrero JJ; Grams ME; Sang Y; Arnlov J; Gasparini A; Matsushita K; Qureshi AR; Evans M; Barany P; Lindholm B; Ballew SH; Levey AS; Gansevoort RT; Elinder CG; Coresh J
Article: TRANSPLANTATION DIRECT. 2016;2(12):e116
Increased Telomere Attrition After Renal Transplantation-Impact of Antimetabolite Therapy
Luttropp K; Nordfors L; McGuinness D; Wennberg L; Curley H; Quasim T; Genberg H; Sandberg J; Sonnerborg I; Schalling M; Qureshi AR; Barany P; Shiels PG; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(12):2086-2094
Prevalence and recognition of chronic kidney disease in Stockholm healthcare
Gasparini A; Evans M; Coresh J; Grams ME; Norin O; Qureshi AR; Runesson B; Barany P; Arnlov J; Jernberg T; Wettermark B; Elinder CG; Carrero J-J
Article: BONE. 2016;92:50-57
Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients
Chen Z; Qureshi AR; Ripsweden J; Wennberg L; Heimburger O; Lindholm B; Barany P; Haarhaus M; Brismar TB; Stenvinkel P
Article: PLOS ONE. 2016;11(10):e0163826
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: PEDIATRIC NEPHROLOGY. 2016;31(9):1485-1497
Assessing longitudinal trends in cardiac function among pediatric patients with chronic kidney disease
Lindblad YT; Vavilis G; Axelsson J; Herthelius M; Barany P
Article: NITRIC OXIDE-BIOLOGY AND CHEMISTRY. 2016;58:1-9
Peritoneal dialysis impairs nitric oxide homeostasis and may predispose infants with low systolic blood pressure to cerebral ischemia
Carlstrom M; Cananau C; Checa A; Wide K; Sartz L; Svensson A; Wheelock CE; Westphal S; Bekassy Z; Barany P; Lundberg JO; Hansson S; Weitzberg E; Krmar RT
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(8):1320-1327
Dialysis modality and nutritional status are associated with variability of inflammatory markers
Snaedal S; Qureshi AR; Lund SH; Germanis G; Hylander B; Heimburger O; Carrero JJ; Stenvinkel P; Barany P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2016;11(7):1163-1172
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
Sun J; Axelsson J; Machowska A; Heimburger O; Barany P; Lindholm B; Lindstrom K; Stenvinkel P; Qureshi AR
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i467
MP383LOW BONE MINERAL DENSITY OF LEGS AND FEMORAL NECK ASSOCIATES WITH CORONARY CALCIFICATION SCORE IN FEMALE END-STAGE RENALDISEASE PATIENTS
Chen Z; Qureshi AR; Haarhaus M; Olauson H; Heimburger O; Barany P; Ripsweden J; Brismar T; Bergström I; Lindholm B; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i183-i184
SP286PLASMA BETA TRACE PROTEIN PREDICTS MORTALITY IN CKD: RELATION WITH ENDOTHELIAL DYSFUNCTION
Van Craenenbroeck A; Qureshi AR; Bragfors-Helin A-C; Simonsson P; Lindholm B; Barany P; Anderstam B; Heimbürger O; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i167
SP242GLOMERULAR FILTRATION RATE ESTIMATION USING BETA TRACE PROTEIN: EXTERNAL VALIDATION OF THREE EQUATIONS
Van Craenenbroeck AH; Qureshi AR; Bragfors-Helin A-C; Simonsson P; Lindholm B; Barany P; Anderstam B; Stenvinkel P; Heimbürger O
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i191-i192
SP306PREVALENCE, DIAGNOSIS AND NEPHROLOGY CARE OF CKD IN THE REGION OF STOCKHOLM
Gasparini A; Evans M; Qureshi AR; Ärnlöv J; Barany P; Coresh J; Wettermark B; Elinder C-G; Carrero J-J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i449
MP330LOWER CALCIUM IS ASSOCIATED WITH KIDNEY FUNCTION DECLINE IN INDIVIDUALS WITH CHRONICKIDNEY DISEASE
Janmaat CJ; van Diepen M; Gasparini A; Evans M; Qureshi AR; Arnlov J; Barany P; Elinder CG; Rotmans JI; Vervloet M; Dekker FW; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i208
SP356PULMONARY DYSFUNCTION IS LINKED TO MALNUTRITION AND INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS
Pei M; Mukai H; Barany P; Chen Z; Heimbürger O; Lindholm B; Stenvinkel P; Qureshi AR
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i334
SP713THE FGF23 AND KLOTHO AXIS IN PEDIATRIC CKD - A PROSPECTIVE COHORT STUDY
Lindblad YT; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i516
MP528SKIN AUTOFLUORESCENCE (SAF), A MARKER OF TISSUE ADVANCED GLYCATED END-PRODUCTS (AGE), AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS
Mukai H; Svedberg O; Chen Z; Lindholm B; Eriksson M; Bragfors-Helin A-C; Heimbürger O; Barany P; Qureshi AR; Anderstam B; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i92-i93
SP019IS END-STAGE POLYCYSTIC KIDNEY DISEASE ASSOCIATED WITH IMPAIRMENT OF GLUCOSE METABOLISM?
Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: PERITONEAL DIALYSIS INTERNATIONAL. 2016;36(3):269-276
ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND WORSE CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS
Isoyama N; Machowska A; Qureshi AR; Yamamoto T; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: CLINICAL KIDNEY JOURNAL. 2016;9(1):119-127
The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
Runesson B; Gasparini A; Qureshi AR; Norin O; Evans M; Barany P; Wettermark B; Elinder CG; Carrero JJ
Article: JOURNAL OF INTERNAL MEDICINE. 2016;279(2):173-179
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
Sjoberg B; Qureshi AR; Heimburger O; Stenvinkel P; Lind L; Larsson A; Barany P; Arnlov J
Article: PLOS ONE. 2016;11(1):e0141738
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
Missailidis C; Hallqvist J; Qureshi AR; Barany P; Heimburger O; Lindholm B; Stenvinkel P; Bergman P
Article: KIDNEY INTERNATIONAL. 2015;88(6):1356-1364
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Qureshi AR; Olauson H; Witasp A; Haarhaus M; Brandenburg V; Wernerson A; Lindholm B; Soderberg M; Wennberg L; Nordfors L; Ripsweden J; Barany P; Stenvinkel P
Article: JOURNAL OF NEPHROLOGY. 2015;28(4):503-510
Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients
Cobo G; Gallar P; Gama-Axelsson T; Di Gioia C; Qureshi AR; Camacho R; Vigil A; Heimburger O; Ortega O; Rodriguez I; Carlos Herrero J; Barany P; Lindholm B; Stenvinkel P; Carrero JJ
Article: PLOS ONE. 2015;10(7):e0132353
Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
Meuwese CL; Olauson H; Qureshi AR; Ripsweden J; Barany P; Vermeer C; Drummen N; Stenvinkel P
Article: PERITONEAL DIALYSIS INTERNATIONAL. 2015;35(4):460-470
INCREASED LEVELS OF MODIFIED ADVANCED OXIDATION PROTEIN PRODUCTS ARE ASSOCIATED WITH CENTRAL AND PERIPHERAL BLOOD PRESSURE IN PERITONEAL DIALYSIS PATIENTS
Xu H; Cabezas-Rodriguez I; Qureshi AR; Heimburger O; Barany P; Snaedal S; Anderstam B; Helin A-CB; Carrero JJ; Stenvinkel P; Lindholm B
Journal article: LAKARTIDNINGEN. 2015;112:DI7D
[The council for new therapies should immediately revoke their decision on eculizumab].
Karpman D; Fehrman-Ekholm I; Bárány P; Békássy Z; Brandström P; Bruchfeld A; Celsi G; Chromek M; Clyne N; Fellström B; Hansson S; Haraldsson B; Nevéus T; Rippe B; Sartz L; Segelmark M; Stegmayr B; Stenvinkel P; Westman K
Journal article: LAKARTIDNINGEN. 2015;112:DI3F
[The council for new therapies position on eculizumab is unacceptable].
Karpman D; Fehrman-Ekholm I; Bárány P; Békássy Z; Brandström P; Bruchfeld A; Celsi G; Chromek M; Clyne N; Fellström B; Hansson S; Haraldsson B; Nevéus T; Rippe B; Sartz L; Segelmark M; Stegmayr B; Stenvinkel P; Tufveson G; Westman K
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30(suppl_3):iii565
SP564HIGH SENSITIVE TROPONIN T AND TROPONIN I THREE MONTH VARIATION IN PREVALENT HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
Snaedal S; Bárány P; Qureshi AR; Heimbürger O; Stenvinkel P; Löwbeer C; Szummer K
Article: CLINICAL KIDNEY JOURNAL. 2015;8(2):215-218
Plasma nitrate/nitrite removal by peritoneal dialysis might predispose infants with low blood pressure to cerebral ischaemia
Carlstrom M; Wide K; Lundvall M; Cananau C; Svensson A; Lundberg JO; Barany P; Krmar RT
Article: CARDIORENAL MEDICINE. 2015;5(2):89-95
High Levels of Soluble Tumor Necrosis Factor Receptors 1 and 2 and Their Association with Mortality in Patients Undergoing Hemodialysis
Carlsson AC; Carrero J-J; Stenvinkel P; Bottai M; Barany P; Larsson A; Arnlov J
Article: PERITONEAL DIALYSIS INTERNATIONAL. 2015;35(2):206-215
OXIDATIVE DNA DAMAGE AND MORTALITY IN HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
Xu H; Watanabe M; Qureshi AR; Heimburger O; Barany P; Anderstam B; Eriksson M; Stenvinkel P; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30(2):274-282
Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting
Yuan J; Watanabe M; Suliman M; Qureshi AR; Axelsson J; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2015;75(8):652-658
Validation of a competitive ELISA assay for the quantification of human serum hepcidin
Dahlfors G; Stal P; Hansson EC; Barany P; Sisowath C; Onelov L; Nelson D; Eggertsen G; Marmur J; Beshara S
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30(1):84-91
Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients
Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: BLOOD PURIFICATION. 2015;39(4):259-265
Endostatin, Cathepsin S, and Cathepsin L, and Their Association with Inflammatory Markers and Mortality in Patients Undergoing Hemodialysis
Carlsson AC; Carrero J-J; Stenvinkel P; Bottai M; Barany P; Larsson A; Arnlov J
Article: LAKARTIDNINGEN. 2014;111:C7XL
Apropå! Rätt ska vara rätt om Njurknappen och NjuRen - NjuRen på väg in i flera landsting.
Bárány P; Shemeikk T
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2014;9(10):1720-1728
Comparative Associations of Muscle Mass and Muscle Strength with Mortality in Dialysis Patients
Isoyama N; Qureshi AR; Avesani CM; Lindholm B; Barany P; Heimburger O; Cederholm T; Stenvinkel P; Carrero JJ
Article: CLINICAL KIDNEY JOURNAL. 2014;7(4):373-379
Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
Sjoberg B; Snaedal S; Stenvinkel P; Qureshi AR; Heimburger O; Barany P
Article: CLINICAL KIDNEY JOURNAL. 2014;7(3):275-281
Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients
Danielson K; Beshara S; Qureshi AR; Heimburger O; Lindholm B; Hansson M; Hylander B; Germanis G; Stenvinkel P; Barany P
Article: ANGIOLOGY. 2014;65(5):443-449
Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4
Ghanavatian S; Diep LM; Barany P; Heimburger O; Seeberger A; Stenvinkel P; Rohani M; Agewall S
Article: CLINICAL KIDNEY JOURNAL. 2014;7(2):151-155
Systematic conversion to generic tacrolimus in stable kidney transplant recipients
Rosenborg S; Nordstrom A; Almquist T; Wennberg L; Barany P
Article: PLOS ONE. 2014;9(1):e86630
Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method
Bobrowski L; Lukaszuk T; Lindholm B; Stenvinkel P; Heimburger O; Axelsson J; Barany P; Carrero JJ; Qureshi AR; Luttropp K; Debowska M; Nordfors L; Schalling M; Waniewski J
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2014;9(1):120-127
IGF-1 and Survival in ESRD
Jia T; Gama Axelsson T; Heimburger O; Barany P; Lindholm B; Stenvinkel P; Qureshi AR
Article: BLOOD PURIFICATION. 2014;37(2):138-145
Determinants of N-Terminal Pro-Brain Natriuretic Peptide Variation in Hemodialysis Patients and Prediction of Survival
Snaedal S; Qureshi AR; Carrero JJ; Heimburger O; Stenvinkel P; Barany P
Journal article: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 2013;23:s52-s53
Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease
Lindblad YT; Axelsson J; Bárány P; Celsi G; Lindholm B; Qureshi AR; Carrea A; Canepa A
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(6):584-593
Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis?
Meuwese CL; Carrero JJ; Cabezas-Rodriguez I; Heimburger O; Barany P; Lindholm B; Qureshi AR; Ripsweden J; Dekker FW; Stenvinkel P
Journal article: LAKARTIDNINGEN. 2013;110(47):2122
[It is better use a modern formula than being formal].
Elinder C-G; Bárány P; Heimbürger O
Article: LAKARTIDNINGEN. 2013;110(47):2119-2120
[Drug dosage should be based on renal function].
Elinder C-G; Bárány P; Heimbürger O
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28:iv175-iv181
Subclinical versus overt obesity in dialysis patients: more than meets the eye
Gracia-Iguacel C; Qureshi AR; Avesani CM; Heimburger O; Huang X; Lindholm B; Barany P; Ortiz A; Stenvinkel P; Carrero JJ
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2013;174(3):441-448
Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality
Frostegard AG; Hua X; Su J; Carrero JJ; Heimburger O; Barany P; Stenvinkel P; Frostegard J
Article: PEDIATRIC NEPHROLOGY. 2013;28(10):2003-2013
Left ventricular diastolic dysfunction by tissue Doppler echocardiography in pediatric chronic kidney disease
Lindblad YT; Axelsson J; Balzano R; Vavilis G; Chromek M; Celsi G; Barany P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28(9):2356-2363
Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients
Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28(6):1346-1359
Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement
Locatelli F; Barany P; Covic A; De Francisco A; Del Vecchio L; Goldsmith D; Hoerl W; London G; Vanholder R; Van Biesen W
Article: JOURNAL OF NEPHROLOGY. 2013;26(3):485-494
Determinants and survival implications of low bone mineral density in end-stage renal disease patients
Park S-H; Jia T; Qureshi AR; Barany P; Heimburger O; Larsson TE; Axelsson J; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28(suppl_1):i35-i36
Peritoneal dialysis - clinical
Bertoli S; Stucchi A; Ciurlino D; Musetti C; Meuwese CL; Carrero JJ; Cabezas-Rodriguez I; Heimburger O; Barany P; Lindholm B; Qureshi AR; Ripsweden J; Dekker FW; Stenvinkel P; Eser B; Buyukbakkal M; Yayar O; Yildirim T; Ercan Z; Kali A; Erdogan B; Haspulat A; Merhametsiz O; Akdag S; Ayli M; Keles H; Kendi Celebi Z; Karatan O; Ates K; Lambie M; Chess J; Bankart MJ; Lee HB; Noh H; Do JY; Dorval M; Topley N; Davies SJ; van Diepen ATN; van Esch S; Krediet RT; Struijk DG
Article: JOURNAL OF INTERNAL MEDICINE. 2013;273(3):263-272
Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients
Huang X; Stenvinkel P; Qureshi AR; Cederholm T; Barany P; Heimburger O; Lindholm B; Riserus U; Carrero JJ
Article: JOURNAL OF RENAL NUTRITION. 2013;23(2):106-113
Self-Rated Appetite as a Predictor of Mortality in Patients With Stage 5 Chronic Kidney Disease
Gama-Axelsson T; Lindholm B; Barany P; Heimbuerger O; Stenvinkel P; Qureshi AR
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2013;37(5):462-471
Determinants of Fibroblast Growth Factor-23 and Parathyroid Hormone Variability in Dialysis Patients
Jia T; Qureshi AR; Brandenburg V; Ketteler M; Barany P; Heimburger O; Uhlin F; Magnusson P; Fernstrom A; Lindholm B; Stenvinkel P; Larsson TE
Journal article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;7(11):1915
Serum albumin as predictor of nutritional status in patients with ESRD (vol 7, pg 1446, 2012)
Gama-Axelsson T; Heimbuerger O; Stenvinkel P; Barany P; Lindholm B; Qureshi AR
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(11):3973-3974
The enigma of decreased creatinine generation in acute kidney injury
Heimbuerger O; Stenvinkel P; Barany P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(9):3615-3620
Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients
Huang X; Stenvinkel P; Qureshi AR; Riserus U; Cederholm T; Barany P; Heimburger O; Lindholm B; Carrero JJ
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;7(9):1446-1453
Serum Albumin as Predictor of Nutritional Status in Patients with ESRD
Gama-Axelsson T; Heimburger O; Stenvinkel P; Barany P; Lindholm B; Qureshi AR
Article: JOURNAL OF RENAL NUTRITION. 2012;22(2):277-283
Plasma Fatty Acids in Chronic Kidney Disease: Nervonic Acid Predicts Mortality
Shearer GC; Carrero JJ; Heimbuerger O; Barany P; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(2):709-715
Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease
Carrero JJ; Barany P; Yilmaz MI; Qureshi AR; Sonmez A; Heimburger O; Ozgurtas T; Yenicesu M; Lindholm B; Stenvinkel P
Article: BLOOD PURIFICATION. 2012;34(3-4):290-297
Pentraxin 3, a Sensitive Early Marker of Hemodialysis-Induced Inflammation
Sjoberg B; Qureshi AR; Anderstam B; Alvestrand A; Barany P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;7(1):131-138
Baseline Levels and Trimestral Variation of Triiodothyronine and Thyroxine and Their Association with Mortality in Maintenance Hemodialysis Patients
Meuwese CL; Dekker FW; Lindholm B; Qureshi AR; Heimburger O; Barany P; Stenvinkel P; Carrero JJ
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(1):70-75
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease
Breit SN; Carrero JJ; Tsai VW-W; Yagoutifam N; Luo W; Kuffner T; Bauskin AR; Wu L; Jiang L; Barany P; Heimburger O; Murikami M-A; Apple FS; Marquis CP; Macia L; Lin S; Sainsbury A; Herzog H; Law M; Stenvinkel P; Brown DA
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2011;6(12):2785-2791
Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease
Miyamoto T; Qureshi AR; Heimburger O; Barany P; Carrero K; Sjoberg B; Lindholm B; Stenvinkel P; Carrero JJ
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;26(10):3237-3242
New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria
Smerud HK; Barany P; Lindstrom K; Fernstrom A; Sandell A; Pahlsson P; Fellstrom B
Article: JOURNAL OF NEPHROLOGY. 2011;24(5):589-596
Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease
Wikstrom B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL
Journal article: CLINICAL KIDNEY JOURNAL. 2011;4(suppl_2):4.s2.9
Treatment of malnutrition and anaemia
Xu Z; Chen Y; Huang A; Varghese Z; Moorhead J; Powis S; Li Q; Ruan X; Espe KM; Raila J; Henze A; Krane V; Schweigert FJ; Hocher B; Wanner C; Drechsler C; Sahni N; Gupta KL; Prasad R; Rana SV; Bhalla A; Carrero JJ; Barany P; Yilmaz MI; Qureshi AR; Sonmez A; Heimburger O; Ozgurtas T; Yenicesu M; Lindholm B; Stenvinkel P; Schneider A; Drechsler C; Krane V; Krieter DH; Fraass U; Schneider MP; Wanner C; Leu K; Mortensen R; Worth A; Singh S; Schatz P; Young P; Wojchowski D; Green J
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2011;6(5):1001-1008
Circulating Follistatin in Patients with Chronic Kidney Disease: Implications for Muscle Strength, Bone Mineral Density, Inflammation, and Survival
Miyamoto T; Carrero JJ; Qureshi AR; Anderstarn B; Heimburger O; Barany P; Lindholm B; Stenvinkel P
Article: KIDNEY INTERNATIONAL. 2011;79(7):749-756
Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients
Carrero JJ; Nakashima A; Qureshi AR; Lindholm B; Heimburger O; Barany P; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;26(4):1313-1318
Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients
Meuwese CL; Snaedal S; Halbesma N; Stenvinkel P; Dekker FW; Qureshi AR; Barany P; Heimburger O; Lindholm B; Krediet RT; Boeschoten EW; Carrero JJ
Article: CLINICAL NEPHROLOGY. 2011;75:S4-S10
Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange
Krmar RT; Holtback U; Linne T; Berg UB; Celsi G; Soderberg MP; Wernerson A; Szakos A; Larsson S; Skatturn L; Barany P
Journal article: CLINICAL NUTRITION. 2011;6(1):156
PP112-MON SELF-RATED APPETITE IS A POOR PREDICTOR OF MORTALITY IN PRE-DIALYSIS AND DIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
Axelsson TG; Lindholm B; Heimburger O; Stenvinkel P; Barany P; Qureshi AR
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;26(1):184-190
Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease
Carrero JJ; Qureshi AR; Nakashima A; Arver S; Parini P; Lindholm B; Barany P; Heimbuerger O; Stenvinkel P
Journal article: CLINICAL NUTRITION. 2011;6(1):156
PP111-MON SERUM ALBUMIN (S-ALB) AS PREDICTOR OF NUTRITIONAL STATUS AND MORTALITY IN END-STAGE RENAL DISEASE (ESRD) PATIENTS (PTS)
Axelsson TG; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2011;33(1):17-24
Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis
Cordeiro AC; Carrero JJ; Barany P; Qureshi AR; Heimburger O; Lindholm B; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(12):4017-4023
Clinical importance of an elevated circulating chemerin level in incident dialysis patients
Yamamoto T; Qureshi AR; Anderstam B; Heimburger O; Barany P; Lindholm B; Stenvinkel P; Axelsson J
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2010;5(12):2213-2219
Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients
Nakashima A; Carrero JJ; Qureshi AR; Miyamoto T; Anderstam B; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(11):3717-3723
Variations in C-reactive protein during a single haemodialysis session do not associate with mortality
Meuwese CL; Halbesma N; Stenvinkel P; Dekker FW; Molanaei H; Qureshi AR; Barany P; Heimburger O; Lindholm B; Krediet RT; Boeschoten EW; Carrero JJ
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(9):3033-3038
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
Olauson H; Qureshi AR; Miyamoto T; Barany P; Heimburger O; Lindholm B; Stenvinkel P; Larsson TE
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(3):901-906
Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels
Carrero JJ; Witasp A; Stenvinkel P; Qureshi AR; Heimburger O; Barany P; Suliman ME; Anderstam B; Lindholm B; Nordfors L; Schalling M; Axelsson J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(2):562-568
Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis
Cordeiro AC; Qureshi AR; Stenvinkel P; Heimburger O; Axelsson J; Barany P; Lindholm B; Carrero JJ
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2009;54(6):1072-1080
Soluble CD14 Levels, Interleukin 6, and Mortality Among Prevalent Hemodialysis Patients
Raj DSC; Carrero JJ; Shah VO; Qureshi AR; Barany P; Heimburger O; Lindholm B; Ferguson J; Moseley PL; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009;24(11):3468-3473
Associations of VEGF and its receptors sVEGFR-1 and-2 with cardiovascular disease and survival in prevalent haemodialysis patients
Guo Q; Carrero JJ; Yu X; Barany P; Qureshi AR; Eriksson M; Anderstam B; Chmielewski M; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009;24(11):3454-3460
Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis
Carrero JJ; Hua X; Stenvinkel P; Qureshi AR; Heimburger O; Barany P; Lindholm B; Frostegard J
Article: TRANSPLANT INTERNATIONAL. 2009;22(11):1051-1057
Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking
Elinder C-G; Ekberg H; Barany P; Fehrman-Ekholm I; Jensen G; Norden G; Schon S; Wennberg L; Qureshi AR
Article: JOURNAL OF NEPHROLOGY. 2009;22(6):774-782
Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease
Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimburger O; Barany P; Alvestrand A; Lindholm B; Suliman ME
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2009;53(6):1024-1033
Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient Survival
Snaedal S; Heimburger O; Qureshi AR; Danielsson A; Wikstrom B; Fellstrom B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Barany P
Article: JOURNAL OF INTERNAL MEDICINE. 2009;265(6):708-716
Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients
Chmielewski M; Carrero JJ; Qureshi AR; Axelsson J; Heimburger O; Berglund L; Barany P; Rutkowski B; Lindholm B; Stenvinkel P
Article: CLINICAL NEPHROLOGY. 2009;71(4):397-404
Intercurrent events and comorbid conditions influence hemoglobin level variability in dialysis patients
DeFrancisco ALM; Macdougall IC; Carrera F; Braun J; Barany P; Bridges I; Wheeler T; Tran D; Dietrich A
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009;20(3):613-620
Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
Carrero JJ; Qureshi AR; Parini P; Arver S; Lindholm B; Barany P; Heimburger O; Stenvinkel P
Article: MOLECULAR MEDICINE. 2009;15(3-4):70-75
Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation
Bruchfeld A; Carrero JJ; Qureshi AR; Lindholm B; Barany P; Heimburger O; Hu M; Lin X; Stenvinkel P; Miller EJ
Article: LAKARTIDNINGEN. 2009;106(7):420-421
[Choose the right method fo estimation of kidney function. The nature of the problem determines which method should be used].
Heimbürger O; Bárány P
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2009;29(6):516-523
N-Terminal Pro-Brain Natriuretic Peptide Independently Predicts Protein Energy Wasting and Is Associated with All-Cause Mortality in Prevalent HD Patients
Guo Q; Barany P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2009;29(5):447-453
Serum Retinol-Binding Protein Concentration and Its Association with Components of the Uremic Metabolic Syndrome in Nondiabetic Patients with Chronic Kidney Disease Stage 5
Axelsson J; O'Byrne SM; Blaner WS; Carrero JJ; Bruchfeld A; Heimbuerger O; Barany P; Lindholm B; Stenvinkel P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009;4(1):110-118
Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients
Carrero JJ; Ortiz A; Qureshi AR; Martin-Ventura JL; Barany P; Heimburger O; Marron B; Metry G; Snaedal S; Lindholm B; Egido J; Stenvinkel P; Blanco-Colio LM
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2008;38(11):804-811
Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients
Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Barany P; Snaedal S; Heimbuerger O; Lindholm B; Suliman ME
Article: CLINICA CHIMICA ACTA. 2008;395(1-2):106-110
Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients
Valli A; Carrero JJ; Qureshi AR; Garibotto G; Barany P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
Article: CLINICAL NUTRITION. 2008;27(4):557-564
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimburger O; Barany P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2008;3(4):976-985
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease
Suliman ME; Yimaz MI; Carrero JJ; Qureshi AR; Saglam M; Ipcioglu OM; Yenicesu M; Tong M; Heimbuerger O; Barany P; Alvestrand A; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2008;87(6):1860-1866
Consequences of low plasma histidine in chronic kidney disease patients:: associations with inflammation, oxidative stress, and mortality
Watanabe M; Suliman ME; Qureshi AR; Garcia-Lopez E; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. 2008;101(5):397-405
The long pentraxin PTX-3 in prevalent hemodialysis patients:: associations with comorbidities and mortality
Suliman ME; Qureshi AR; Carrero JJ; Barany P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimburger O; Lindholm B; Stenvinkel P
Article: MOLECULAR MEDICINE. 2008;14(3-4):109-115
High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)
Bruchfeld A; Qureshi AR; Lindholm B; Barany P; Yang L; Stenvinkel P; Tracey KJ
Article: JOURNAL OF INTERNAL MEDICINE. 2008;263(3):302-312
Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients
Carrero JJ; Stenvinkel P; Fellstrom B; Qureshi AR; Lamb K; Heimburger O; Barany P; Radhakrishnan K; Lindholm B; Soveri I; Nordfors L; Shiels PG
Journal article: CLINICAL NUTRITION. 2008;3:156-157
P300 MUSCLE ATROPHY, INFLAMMATION AND CLINICAL OUTCOME IN INCIDENT AND PREVALENT DIALYSIS PATIENTS
Carrero JJ; Chmielewski M; Heimburger O; Barany P; Lindholm B; Qureshi AR; Stenvinkel P
Article: BLOOD PURIFICATION. 2008;26(3):284-290
Bone mineral density in end-stage renal disease patients:: Association with wasting, cardiovascular disease and mortality
Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbuerger O; Barany P; Stenvinkel P; Lindholm B
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2008;28(4):669-676
Is fetuin-A/α2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
Axelsson J; Wang X; Ketteler M; Qureshi AR; Heimburger O; Barany P; Lindholm B; Nordfors L; Stenvinkel P
Article: BLOOD PURIFICATION. 2008;26(6):555-560
Lipoprotein Lipase 1595 C/G and Hepatic Lipase-480 C/T Polymorphisms - Impact on Lipid Profile in Incident Dialysis Patients
Chmielewski M; Stenvinkel P; Luttropp K; Suliman ME; Qureshi AR; Carrero JJ; Barany P; Heimburger O; Nordfors L; Lindholm B
Article: BLOOD PURIFICATION. 2008;26(6):518-525
Hyperinsulinemia and Insulin Resistance, Early Cardiovascular Risk Factors in Children with Chronic Kidney Disease
Lindblad YT; Axelsson J; Barany P; Celsi G; Lindholm B; Qureshi AR; Carrea A; Canepa A
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(12):3586-3592
Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients
Girndt M; Stenvinkel P; Ulrich C; Axelsson J; Nordfors L; Barany P; Carrero JJ; Heine GH; Kaul H; Koehler H
Article: JOURNAL OF INTERNAL MEDICINE. 2007;262(6):690-701
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease
Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Barany P; Heimburger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
Article: SEMINARS IN DIALYSIS. 2007;20(6):523-529
Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients
Suliman ME; Lindholm B; Barany P; Qureshi AR; Stenvinkel P
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2007;86(3):633-638
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality
Honda H; Qureshi AR; Axelsson J; Heimburger O; Suliman ME; Barany P; Stenvinkel P; Lindholm B
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2007;2(5):889-897
Plasma pentraxin 3 in patients with chronic kidney disease:: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality
Tong M; Carrero JJ; Qureshi AR; Anderstam B; Heimburger O; Barany P; Axelsson J; Alvestrand A; Stenvinkel P; Lindholm B; Suliman ME
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(9):2571-2577
Association between oestrogen receptor α gene polymorphism and mortality in female end-stage renal disease patients
Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimburger O; Gustafsson J-A; Stenvinkel P; Nordfors L
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:iv10-iv18
Maintaining control over haemoglobin levels:: optimizing the management of anaemia in chronic kidney disease
Barany P; Mueller H-J
Article: JOURNAL OF INTERNAL MEDICINE. 2007;261(5):488-499
Impact of inflammation on epigenetic DNA methylation -: a novel risk factor for cardiovascular disease?
Stenvinkel P; Karimi M; Johansson S; Axelsson J; Suliman M; Lindholm B; Heimburger O; Barany P; Alvestrand A; Nordfors L; Qureshi AR; Ekstrom TJ; Schalling M
Article: CLINICA CHIMICA ACTA. 2007;379(1-2):87-94
Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors
Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2007;85(3):695-701
Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetites
Carrero JJ; Qureshi AR; Axelsson J; Avesani CM; Suliman ME; Kato S; Barany P; Snaedal-Jonsdottir S; Alvestrand A; Heimburger O; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2007;49(2):237-244
Circulating levels of Visfatin/Pre-B-Cell colony-enhancing factor 1 in relation to genotype,GFR, body composition, and survival in patients with CKD
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbuerger O; Barany P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Article: ORAL HEALTH & PREVENTIVE DENTISTRY. 2007;5(3):235-244
Oral health and pro-inflammatory status in end-stage renal disease patients.
Buhlin K; Bárány P; Heimbürger O; Stenvinkel P; Gustafsson A
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(1):209-217
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Barany P; Heimburger O; Vonesh EF; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(1):196-202
Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism
Wang X; Axelsson J; Nordfors L; Qureshi AR; Avesani C; Barany P; Schalling M; Heimburger O; Lindholm B; Stenvinkel P
Article: BLOOD PURIFICATION. 2007;25(2):210-218
Associations between the CYBA 242C/T and the MPO-463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients
Grahl DA; Axelsson J; Nordfors L; Heimburger O; Barany P; Qureshi AR; Kato S; Watanabe M; Suliman M; Riella MC; Lindholm B; Stenvinkel P; Pecoits-Filho R
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;48(6):916-925
Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD
Axelsson J; Moller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimburger O; Barany P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Article: CLINICAL NEPHROLOGY. 2006;66(6):418-425
Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy
Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Barany P; Heimburger O; Lindholm B
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;48(5):761-771
J-shaped mortality relationship for uric acid in CKD
Suliman ME; Johnson RJ; Garcia-Lopez E; Qureshi AR; Molinaei H; Carrero JJ; Heimburger O; Barany P; Axelsson J; Lindholm B; Stenvinkel P
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2006;60(6):718-726
Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
Axelsson J; Qureshi AR; Divino-Filho JC; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2006;1(2):281-287
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients
Stenvinkel P; Rodriguez-Ayala E; Massy ZA; Qureshi AR; Barany P; Fellstrom B; Heimburger O; Lindholm B; Alvestrand A
Article: KIDNEY INTERNATIONAL. 2006;69(3):596-604
Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance
Axelsson J; Bergsten A; Qureshi AR; Heimbürger O; Bárány P; Lönnqvist FL; Lindholm B; Nordfors L; Alvestrand A; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;47(1):139-148
Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21(1):125-132
Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging
Hayashi SY; Rohani M; Lindholm B; Brodin L; Lind B; Barany P; Alvestrand A; Seeberger A
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2005;46(4):628-634
Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD
Axelsson J; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P; Bárány P
Article: LAKARTIDNINGEN. 2005;102(37):2536-2537
[Iron deficiency in renal anemia is difficult to diagnose. Evidence-based guidelines improve diagnosis and treatment].
Bárány P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:2-7
Inflammation and resistance to erythropoiesis-stimulating agents - what do we know and what needs to be clarified?
Smrzova J; Balla J; Bárány P
Article: ATHEROSCLEROSIS. 2005;182(1):105-111
Peroxisome proliferator-activated receptor γ polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy
Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20 Suppl 8:viii2-viii7
Inflammation and resistance to erythropoiesis-stimulating agents--what do we know and what needs to be clarified?
Smrzova J; Balla J; Bárány P
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2005;82(2):342-349
Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease
Suliman ME; Qureshi AR; Stenvinkel P; Pecoits R; Bárány P; Heimbürger O; Anderstam B; Ayala ER; Divino JC; Alvestrand A; Lindholm B
Article: KIDNEY INTERNATIONAL. 2005;67(6):2383-2392
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin
Stenvinkel P; Wang K; Qureshi AR; Axelsson J; Pecoits R; Gao P; Barany P; Lindholm B; Jogestrand T; Heimbürger O; Holmes C; Schalling M; Nordfors L
Article: LAKARTIDNINGEN. 2005;102(5):281-282
[Selection of dialysis type--a crucial decision. Peritoneal dialysis is better for the patient and cheaper for the society].
Jonsdottir SS; Stenvinkel P; Bárány P
Article: BLOOD PURIFICATION. 2005;23(5):384-393
Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease
Maruyama Y; Nordfors L; Stenvinkel P; Heimbürger O; Bárány P; Pecoits R; Axelsson J; Hoff CM; Holmes CJ; Schalling M; Lindholm B
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2004;44(3):455-465
Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy
Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimbürger O; Anderstam B; Alvestrand A; Lindholm B
Journal article: JOURNAL OF NEPHROLOGY. 2004;17(4):525-530
Varying intervals of subcutaneous epoetin alfa in hemodialysis patients
Beshara S; Bárány P; Gutierrez A; Wikström B
Article: JOURNAL OF NEPHROLOGY. 2004;17(4):525-530
Varying intervals of subcutaneous epoetin alfa in hemodialysis patients
Beshara S; Bárány P; Gutierrez A; Wikström B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19(7):1823-1828
Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease
Nascimento MM; Qureshi AR; Stenvinkel P; Pecoits-Filho R; Heimbürger O; Cederholm T; Lindholm B; Bárány P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19 Suppl 2:ii1
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.
Locatelli F; Aljama P; Bárány P; Canaud B; Carrera F; Eckardt K-U; Hörl WH; Macdougal IC; Macleod A; Wiecek A; Cameron S; European Best Practice Guidelines Working Group
Article: KIDNEY INTERNATIONAL. 2004;65(1):274-281
Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin
Stenvinkel P; Marchlewska A; Pecoits R; Heimbürger O; Zhang ZZ; Hoff C; Holmes C; Axelsson J; Arvidsson S; Schalling M; Barany P; Lindholm B; Nordfors L
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2003;41(6):1212-1218
Associations between circulating inflammatory markers and residual renal function in CRF patients
Pecoits R; Heimbürger O; Bárány P; Suliman M; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14(6):1614-1622
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy
Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits R; Ayala ER; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2002;40(6):E22-e22.4
Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor
Donne RL; Abbs I; Barany P; Elinder CG; Little M; Conlon P; Goodship THJ
Article: KIDNEY INTERNATIONAL. 2002;62(6):2167-2175
Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients
Vanrenterghem Y; Bárány P; Mann JFE; Kerr PG; Wilson J; Baker NF; Gray SJ
Article: LAKARTIDNINGEN. 2002;99(42):4162-4163
[Unusual but serious adverse effect. Epoetin treatment of patients with kidney diseases caused erythroblastopenia].
Stenvinkel P; Bárány P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2002;40(3):480-488
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(9):1684-1688
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment
Pecoits-Filho R; Bárány P; Lindholm B; Heimbürger O; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(7):1266-1274
A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients
Stenvinkel P; Barany P; Chung SH; Lindholm B; Heimbürger O
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(6):1050-1056
Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease
Suliman ME; Bárány P; Divino JC; Qureshi AR; Stenvinkel P; Heimbürger O; Anderstam B; Lindholm B; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2001;16(3):580-584
Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers
Bárány P; Stenvinkel B; Ottosson-Seeberger A; Alvestrand A; Morrow J; Roberts JJ; Salahudeen AK
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2001;16(2):224-227
Inflammation, serum C-reactive protein, and erythropoietin resistance
Bárány P
Article: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2001;39(8):734-738
Hyperhomocysteinemia in chronic renal failure patients: Relation to nutritional status and cardiovascular disease
Suliman ME; Lindholm B; Bárány P; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2001;16(1):102-110
Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients
Suliman ME; Divino JC; Bárány P; Anderstam B; Lindholm B; Bergström J
Article: JOURNAL OF RENAL CARE. 1999;25(4):42-44
An educational programme for persistent life-style changes in patients with chronic renal disease.
Bergström K; Bárány P; Holm I
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1999;10(6):1287-1296
Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients
Suliman ME; Divino JC; Bàràny P; Anderstam B; Lindholm B; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 1997;12(11):2339-2348
Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uraemic patients
Divino JC; Barany P; Stehle P; Furst P; Bergstrom J
Article: CLINICAL NEPHROLOGY. 1997;48(1):1-8
Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients
Drueke TB; Barany P; Cazzola M; Eschbach JW; Grutzmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; vanWyck D
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 1997;29(4):565-568
High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients
Barany P; Divino JC; Bergstrom J
Article: PERITONEAL DIALYSIS INTERNATIONAL. 1995;15(1):54-60
SUBCUTANEOUS EPOETIN-BETA IN RENAL ANEMIA - AN OPEN MULTICENTER DOSE TITRATION STUDY OF PATIENTS ON CONTINUOUS PERITONEAL-DIALYSIS
BARANY P; CLYNE N; HYLANDER B; JOHANSSON AC; SIMONSEN O; LARSSON R; FRISENETTEFICH C; SVENSSON B; HELMERS C
Journal article: BIODRUGS. 1994;1(6):469-480
IMMUNOLOGICAL ASPECTS OF HEMODIALYSIS
BARANY P; FEHRMANEKHOLM I
Journal article: DIALYSIS AND TRANSPLANTATION. 1994;23(1):30-36
PERITONEAL TRANSPORT AND EPO
HEIMBURGER O; BARANY P; TRANAEUS A; WANIEWSKI J; WERYNSKI A; PARK MS; LINDHOLM B
Journal article: CLINICAL NEPHROLOGY. 1993;40(3):168-175
DAILY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) IN PERITONEAL-DIALYSIS PATIENTS - A EUROPEAN DOSE-RESPONSE STUDY
FALLER B; SLINGENEYER A; WALLER M; MICHEL C; GRUTZMACHER P; MULLER HP; BARANY P; GRABENSEE B; ISSAD B; SCHMITT H; MEISL F
Journal article: CLINICAL SCIENCE. 1993;84(4):441-447
TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS WITH ERYTHROPOIETIN - LONG-TERM EFFECTS ON EXERCISE CAPACITY
BARANY P; FREYSCHUSS U; PETTERSSON E; BERGSTROM J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 1993;8(5):426-432
LONG-TERM EFFECTS ON QUALITY-OF-LIFE IN HEMODIALYSIS-PATIENTS OF CORRECTION OF ANEMIA WITH ERYTHROPOIETIN
BARANY P; PETTERSSON E; KONARSKISVENSSON JK
Journal article: CLINICAL NEPHROLOGY. 1992;38(1):53-57
CLOSTRIDIUM-DIFFICILE INFECTION - A POOR PROGNOSTIC SIGN IN UREMIC PATIENTS
BARANY P; STENVINKEL P; NORD CE; BERGSTROM J
Journal article: CLINICAL NEPHROLOGY. 1992;37(2):90-96
LONG-TERM EFFECTS ON LYMPHOCYTOTOXIC ANTIBODIES AND IMMUNE REACTIVITY IN HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
BARANY P; FEHRMAN I; GODOY C
Journal article: CLINICAL SCIENCE. 1991;81(5):645-653
ATP PRODUCTION IN ISOLATED MUSCLE MITOCHONDRIA FROM HEMODIALYSIS-PATIENTS - EFFECTS OF CORRECTION OF ANEMIA WITH ERYTHROPOIETIN
BARANY P; WIBOM R; HULTMAN E; BERGSTROM J
Journal article: LAKARTIDNINGEN. 1991;88(36):2855-2857
[Erythropoietin is highly effective in renal anemia but should be prescribed with caution].
Bárány P
Journal article: CLINICAL NEPHROLOGY. 1991;35(6):270-279
NUTRITIONAL ASSESSMENT IN ANEMIC HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
BARANY P; PETTERSON E; AHLBERG M; HULTMAN E; BERGSTROM J
Journal article: CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY. 1991;88:169-179
Long-term effects of recombinant human erythropoietin in patients treated with continuous peritoneal dialysis: safety aspects.
Bárány P; Tranaeus A; Bergström J
Journal article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 1990;50(3):337-341
DECREASED CONCENTRATIONS OF DEOXYCHOLIC-ACID IN SERUM OF UREMIC PATIENTS WITH DIARRHEA
STENVINKEL P; BARANY P; BJORKHEM I; EINARSSON K
Journal article: TRANSPLANTATION PROCEEDINGS. 1990;22(1):147-148
MEASURES TO DECREASE HLA ANTIBODIES IN IMMUNIZED PATIENTS AWAITING KIDNEY-TRANSPLANTATION
FEHRMAN I; BARANY P; BJORCK S; BERGSTROM J; STELIN G; KONAR J; SANDBERG L; SODERSTROM T; LUNDGREN G; BRYNGER H
Journal article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 1990;131:55-60
ERYTHROPOIETIN TREATMENT IMPROVES QUALITY-OF-LIFE IN HEMODIALYSIS-PATIENTS
BARANY P; PETTERSSON E; BERGSTROM J
Journal article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY. 1987;6(3):352-356
CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA IN UREMIC PATIENTS
ARONSSON B; BARANY P; NORD CE; NYSTROM B; STENVINKEL P
Visa fler

Alla övriga publikationer

Editorial: JOURNAL OF INTERNAL MEDICINE. 2026;300(3):218-219
Continue or discontinue antihypertensive medication in hospitalized patients-The coin has two sides
Barany P
Conference publication: 2026;:a256.1-a2a256
PO:09:245 Risk of severe infection in lupus nephritis patients with chronic kidney disease & comparison to ANCA vasculitis-patients: a nationwide study
Chrysostomou C; Faustini F; Gunnarsson I; Segelmark M; Carrero J-J; Barany P; Evans M; Faucon A-L
Preprint: RESEARCH SQUARE. 2025
Low Fischer’s ratio is associated with increased mortality in patients with kidney failure
Zhang Q; Suliman M; Qureshi AR; Guo F; Troise D; Xu R; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
Preprint: RESEARCH SQUARE. 2025
Plasma branched-chain amino acids in chronic kidney disease: Associations with atherogenic lipids and mortality
Suliman M; Qureshi AR; Troise D; Zhang Q; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
Conference publication: AMERICAN JOURNAL OF HEMATOLOGY. 2025;100
Delta-He Associates with Infectious Focus in Patients with Severe Infections
Pistis KD; Unge C; Parke A; Yu D; Qureshi AR; Beshara S; Barany P; Stralin K
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2025;54:197-198
Temporal trends and determinants of infection in Lupus nephritis patients with chronic kidney disease
Chrysostomou C; Faustini F; Gunnarsson I; Barany P; Evans M; Faucon A-L
Preprint: BIORXIV. 2025
The renal response to FGF23 shifts from phosphaturia towards inflammation in kidney disease
Moor M; Burmakin M; Levin A; Korkut GG; Brodin D; Wernerson A; Bruchfeld A; Bárány P; Witasp A; Patrakka J; Olauson H
Conference publication: PEDIATRIC NEPHROLOGY. 2024;39(1):S253
Focal segmental glomerulosclerosis in the girl with MIRAGE Syndrome
Niwinska-Faryna B; Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2024;39(1):S249
COVID-19-induced tubulointerstitial nephritis in an infant with multisystem inflammatory syndrome
Niwinska-Faryna B; Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2024;39(1):S63
Extracellular DNA in children with chronic kidney disease
Lindblad YT; Tothova L; Celec P; Kublickiene K; Barany P; Chromek M
Conference publication: 2024;:a41-a42
O44 Long-term outcomes of chronic kidney disease patients with lupus nephritis: a nationwide cohort study
Chrysostomou C; Faucon A-L; Faustini F; Gunnarsson I; Barany P; Evans M
Editorial: CLINICAL KIDNEY JOURNAL. 2023;16(10):1541-1542
Lifelong statins for long life in dialysis patients?
Ebert T; Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2023;38:S175-S176
CLINICAL COURSE AND OUTCOME OF THREE ANCA AND ANTI-GBM POSITIVE TEENAGE PATIENTS
Niwinska-Faryna B; Barany P; Chrome M
Conference publication: PEDIATRIC NEPHROLOGY. 2022;37(11):2851-2852
RENAL FUNCTION IN SURVIVORS OF HYPOTHERMIA-TREATED HYPOXIC-ISCHAEMIC ENCEPHALOPATHY AFTER 10-12 YEARS
Grossmann KR; Vishnevskaya L; Blennow M; Barany P; Chromek M
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11):246-247
Burden of Anemia in Patients With CKD Stages 3-5 Managed in Primary Care
Evans M; Xu Y; Mazhar F; Arnlov J; Cockburn E; Barany PF; Carrero JJ
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11):231
Blood-Brain-Barrier Biomarkers in Patients Before and After Kidney Transplantation
Hernandez LN; Ward LJ; Arefin S; Barany PF; Stenvinkel P; Kublickiene K
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:1563
Prognosis after aortic valve replacement in dialysis patients: results from the Swedish Renal Registry
Vavilis G; Back M; Barany P; Ruck A; Szummer K
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022;31:632
Use of potential nephrotoxic medications among adults with CKD: Parallel cohort studies in US and Swedish routine care
Xu Y; Bosi A; Gasparini A; Wettermark B; Barany P; Inker L; Chang A; Grams M; Carrero J; Shin J-I
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37:I901
NOVEL GLUCOSE-LOWERING DRUGS AND THE RISK OF ACUTE KIDNEY INJURY IN ROUTINE CARE: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Alkas J; Bosi A; Sjolander A; Barany FP; Elinder C-G; Fu E; Carrero JJ
Editorial: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;16(11):1613-1614
Muscle Abnormalities with Kidney Failure
Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2021;36(10):3324
ACUTE KIDNEY INJURY AFTER ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN - A SINGLE CENTRE OBSERVATIONAL STUDY
Larsson E; Sundin M; Barany P; Chromek M
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(10):188
Serum Erythroferrone and Serum Hepcidin 25 Are Associated with CKD
Pistis KD; Qureshi ART; Stenvinkel P; Lindholm B; Barany PF
Preprint: RESEARCH SQUARE. 2020
Inverse association of transferrin saturation with mortality risk in chronic kidney disease
Li X; Danielson K; Forsal I; Iseri K; Dai L; Heimbürger O; Bárány P; Yu C; Qureshi AR; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
PENTOSIDINE IN END-STAGE RENAL DISEASE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) VERSUS OTHER ETIOLOGIES
Jankowska M; Qureshi AR; Lu D; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34:165
PREDICTORS OF VASCULAR CALCIFICATION IN END-STAGE RENAL DISEASE PATIENTS
Dai L; Debowska M; Lukaszuk T; Bobrowski L; Pietribiasi M; Barany P; Soderberg M; Wernerson A; Lindholm B; Qureshi AR; Waniewski J; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
THE ASSOCIATION BETWEEN RENAL FUNCTION AND TROPONIN T OVER TIME IN STABLE CKD PATIENTS
Chesnaye N; Szummer K; Barany P; Heimburger O; Magin H; Uhlin F; Dekker FW; Wanner C; Jager K; Evans M
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
SODIUM POLYSTYRENE SULFONATE, PRACTICE PATTERNS AND ASSOCIATED ADVERSE EVENT RISK; A NATIONWIDE ANALYSIS FROM THE SWEDISH RENAL REGISTER
Laureati P; Evans M; Trevisan M; Schalin L; Bellocco R; Sood MM; Barany P; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
56th Congress of the European Renal Association (ERA) & European Dialysis and Transplant Association (EDTA) Budapest, Hungary June 13-16, 2019 Abstracts
Iseri K; Qureshi AR; Dai L; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
FRACTURE RISK IN NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (CKD): INCIDENCE, PREDICTORS AND SEQUELAE
Runesson B; Trevisan M; Iseri K; Bengt L; Peter B; Elinder C-G; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
ACHIEVED BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE STAGE 4-5
Al-Sodany E; Marie E; Olof H; Peter B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34:175
DYNAMIC PREDICTION OF MORTALITY IN ADVANCED CKD USING TROPONIN T
Chesnaye N; Szummer K; Barany P; Heimburger O; Stenvinkel P; Melander S; Dekker FW; Wanner C; Jager K; Evans M
Corrigendum: EUROPEAN JOURNAL OF HEART FAILURE. 2019;21(4):540
'Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists' (vol 20, pg 1217, 2018)
Trevisan M; de Deco P; Xu H; Evans M; Lindholm B; Bellocco R; Barany P; Jernberg T; Lund LH; Carrero JJ
Conference publication: PEDIATRIC NEPHROLOGY. 2018;33(10):1836
AKI IN INFANTS WITH HYPOTHERMIA-TREATED HYPOXIC-ISCHAEMIC ENCEPHALOPATHY
Grossmann KR; Chromek M; Barany P; Blennow M
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
EGFR AND THE RISK OF CANCER: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Xu H; Su G; Trevisan M; Elinder C-G; Barany P; Lindholm B; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
FIBROBLAST GROWTH FACTOR 23 IS ASSOCIATED WITH FRACTIONAL SODIUM EXCRETION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Xu H; Hashem A; Witasp A; Mencke R; Stenvinkel P; Barany P; Bruchfeld A; Wernerson A; Carrero J-J; Olauson H
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
HIGH FIBRINOGEN LEVELS ARE INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
Hasbal NB; Mukai H; Chen Z; Lindholm B; Rger OH; Barany P; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
PLASMA POTASSIUM AND THE RISK OF MORTALITY: A TIME-DEPENDENT ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Trevisan M; Evans M; Xu H; Lindholm B; Barany P; Elinder C-G; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33:444
HIGHER MEAN CORPUSCULAR VOLUME ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS
Mukai H; Lindholm B; Heimburger O; Barany P; Qureshi AR; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
HIGHER NEUTROPHIL TO LYMPHOCYTE RATIO ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS
Mukai H; Kato S; Lindholm B; Heimburger O; Barany P; Washida N; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
INCIDENCE, PREDICTORS AND CLINICAL MANAGEMENT OF HYPERKALEMIA IN NEW USERS OF MINERALOCORTICOID RECEPTOR ANTAGONISTS
Trevisan M; de Deco P; Xu H; Evans M; Lindholm B; Bellocco R; Barany P; Jernberg T; Lund L; Carrero JJ
Conference publication: CIRCULATION. 2017;136
Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
Mok Y; Ballew S; Grams M; Coresh J; Carrero J-J; Evans M; Barany P; Matsushita K
Conference publication: PEDIATRIC NEPHROLOGY. 2017;32(9):1659-1660
THE FGF23 AND KLOTHO AXIS IN PEDIATRIC CHRONIC KIDNEY DISEASE - A PROSPECTIVE COHORT STUDY
Lindblad YT; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Barany P
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:974
Incident atrial fibrillation and the risk of stroke in patients with chronic kidney disease
Szummer K; Trevisan M; Barany P; Xu H; Evans M; Carrero JJ
Meeting abstract: ATHEROSCLEROSIS. 2017;263:e274
PLASMA LIPOPROTEINS IN CHRONIC KIDNEY DISEASE: INCREASED BINDING TO ARTERIAL PROTEOGLYCANS PREDICTS CARDIOVASCULAR MORTALITY
Matteo P; Peter S; Minniti ME; Emma K; Arne D; Sanam E; Monica G; Peter B; Rashid QA; German C; Bengt L; Katariina O; Uwe T; Laura C; Eva H-C; Paolo P
Review: BMJ OPEN. 2017;7(4):e014345
High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines
Eriksen J; Gustafsson LL; Ateva K; Bastholm-Rahmner P; Ovesjo M-L; Jirlow M; Juhasz-Haverinen M; Larfars G; Malmstrom RE; Wettermark B; Andersen-Karlsson E
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32:173
CAUSES OF DEATH ACROSS REDUCED KIDNEY FUNCTION; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Runesson B; Qureshi A; Gasparini A; Barany P; Evans M; Elinder C-G; Wettermark B; Carrero J-J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32:13
INAPPROPRIATE PRESCRIPTION OF NEPHROTOXIC DRUGS TO INDIVIDUALS WITH CHRONIC KIDNEY DISEASE: A COMMUNITY-BASED ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Gasparini A; Wettermark B; Schmidt-Mende K; Evans M; Qureshi AR; Barany P; Elinder C-G; Carrero J-J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
COMBINATION OF GENOTYPE AND PHENOTYPE FEATURES AS PREDICTORS OF INFLAMMATION, CARDIOVASCULAR DISEASE AND PROTEIN ENERGY WASTING IN PATIENTS WITH CHRONIC KIDNEY DISEASES
Debowska M; Lukaszuk T; Nordfors L; Carrero JJ; Qureshi AR; Stenvinkel P; Heimburger O; Barany P; Bobrowski L; Schalling M; Lindholm B; Waniewski J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
KIDNEY FUNCTION AND THE RISK OF COMMUNITY ACQUIRED INFECTIONS
Xu H; Gasparini A; Ishigami J; Mzayen K; Su G; Barany P; Arnlov J; Lindholm B; Elinder CG; Matsushita K; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
CIRCULATING PROTEINS AS PREDICTORS OF CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS - A PROTEOMIC APPROACH
Feldreich T; Fall T; Carlsson A; Jesus-Carrero J; Qureshi A; Heimburger O; Barany P; Stenvinkel P; Arnlov J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
IMPACT OF CINACALCET TREATMENT ON CARDIOVASCULAR OUTCOMES IN CKD PATIENTS WITH SECONDARY HYPERPARATHYROIDISM; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Evans M; Methven S; Sjolander A; May M; MacNeill S; Birnie K; Barany P; Carrero J-J; Caskey F
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
OBSTRUCTIVE AND RESTRICTIVE LUNG FUNCTION ASSOCIATES WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Mukai H; Ming P; Lindholm B; Rger OHSD; Barany P; Stenvinkel P; Qureshi A
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
SUBJECTIVE GLOBAL ASSESSMENT OF NUTRITIONAL STATUS AS PREDICTOR OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS
Dai L; Mukai H; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi A
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
INFLAMMATION MODIFIES THE MORTALITY PREDICTIVE CAPACITY OF OXIDATIVE DNA DAMAGE IN CHRONIC KIDNEY DISEASE PATIENTS
Dai L; Qureshi A; Mukai H; Machowska A; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Meeting abstract: ATHEROSCLEROSIS. 2016;252:E237
WORKSHOP 2.1: LIPOPROTEINS AND EXTRACELLULAR MATRIX. INCREASED LIPOPROTEIN BINDING TO ARTERIAL PROTEOGLYCANS AND NORMAL MACROPHAGE CHOLESTEROL EFFLUX CAPACITY DEFINE THE PRO-ATHEROGENIC FEATURE OF CKD DYSLIPIDEMIA
Pedrelli M; Stenvinkel P; Minniti ME; Emma K; Dikkers A; Ebtehaj S; Gomaraschi M; Barany P; Qureshi AR; Camejo G; Lindholm B; Oorni K; Tietge U; Calabresi L; Hurt-Camejo E; Parini P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:1516
SKIN AUTOFLUORESCENCE (SAF), A MARKER OF TISSUE ADVANCED GLYCATED END-PRODUCTS (AGE), AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS
Mukai H; Svedberg O; Chen Z; Lindholm B; Eriksson M; Bragfors-Helin A-C; Heimburger O; Barany P; Qureshi AR; Anderstam B; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:334
THE FGF23 AND KLOTHO AXIS IN PEDIATRIC CKD - A PROSPECTIVE COHORT STUDY
Lindblad YT; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Barany P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:183-184
PLASMA BETA TRACE PROTEIN PREDICTS MORTALITY IN CKD: RELATION WITH ENDOTHELIAL DYSFUNCTION
Van Craenenbroeck A; Qureshi AR; Bragfors-Helin A-C; Simonsson P; Lindholm B; Barany P; Anderstam B; Heimburger O; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:191-192
PREVALENCE, DIAGNOSIS AND NEPHROLOGY CARE OF CKD IN THE REGION OF STOCKHOLM
Gasparini A; Evans M; Qureshi AR; Arnlov J; Barany P; Coresh J; Wettermark B; Elinder C-G; Carrero J-J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i584-i585
MP738BONE MINERAL DENSITY IN LIVING DONOR RENAL TRANSPLANTATION RECIPENTS ASSOCIATES WITH FIBROBLAST GROWTH FACTOR23
Chen Z; Haarhaus M; Olauson H; Barany P; Wennberg L; Ripsweden J; Brismar T; Bergström I; Lindholm B; Stenvinkel P; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:1449
LOWER CALCIUM IS ASSOCIATED WITH KIDNEY FUNCTION DECLINE IN INDIVIDUALS WITH CHRONICKIDNEY DISEASE
Janmaat CJ; van Diepen M; Gasparini A; Evans M; Qureshi AR; Arnlov J; Barany P; Elinder CG; Rotmans JI; Vervloet M; Dekker FW; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:1584-1585
BONE MINERAL DENSITY IN LIVING DONOR RENAL TRANSPLANTATION RECIPENTS ASSOCIATES WITH FIBROBLAST GROWTH FACTOR23
Chen Z; Haarhaus M; Olauson H; Barany P; Wennberg L; Ripsweden J; Brismar T; Bergstrom I; Lindholm B; Stenvinkel P; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:1467
LOW BONE MINERAL DENSITY OF LEGS AND FEMORAL NECK ASSOCIATES WITH CORONARY CALCIFICATION SCORE IN FEMALE END-STAGE RENALDISEASE PATIENTS
Chen Z; Qureshi AR; Haarhaus M; Olauson H; Heimburger O; Barany P; Ripsweden J; Brismar T; Bergstrom I; Lindholm B; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:208
PULMONARY DYSFUNCTION IS LINKED TO MALNUTRITION AND INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS
Pei M; Mukai H; Barany P; Chen Z; Heimburger O; Lindholm B; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:167
GLOMERULAR FILTRATION RATE ESTIMATION USING BETA TRACE PROTEIN: EXTERNAL VALIDATION OF THREE EQUATIONS
Van Craenenbroeck AH; Qureshi AR; Bragfors-Helin A-C; Simonsson P; Lindholm B; Barany P; Anderstam B; Stenvinkel P; Heimburger O
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:92-93
IS END-STAGE POLYCYSTIC KIDNEY DISEASE ASSOCIATED WITH IMPAIRMENT OF GLUCOSE METABOLISM?
Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Review: KIDNEY INTERNATIONAL. 2016;89(1):28-39
Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Macdougall IC; Bircher AJ; Eckardt K-U; Obrador GT; Pollock CA; Stenvinkel P; Swinkels DW; Wanner C; Weiss G; Chertow GM
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30:iii267
MUSCLE STRENGTH, MUSCLE MASS AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS
Xu H; Cabezas-Rodriguez I; Qureshi AR; Heimburger O; Barany P; Cannata-Andia J; Lindholm B; Stenvinkel P; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30
HIGH SENSITIVE TROPONIN T AND TROPONIN I THREE MONTH VARIATION IN PREVALENT HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
Snaedal S; Barany P; Qureshi AR; Heimburger O; Stenvinkel P; Lowbeer C; Szummer K
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30:iii261
ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS
Isoyama N; Machowska A; Qureshi AR; Yamamoto T; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Bengt L
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30:iii519-iii520
CIRCULATING PLASMA PENTOSIDINE IN PRE-DIALYSIS, PRE-TRANSPLANT, PERITONEAL DIALYSIS (PD) AND HEMODIALYSIS (HD) PATIENTS (PTS)
Machowska A; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Meeting abstract: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30:iii669
A LONGITUDINAL STUDY OF CARDIOVASCULAR FUNCTION IN PEDIATRIC CHRONIC KIDNEY DISEASE AND POST-TRANSPLANT PATIENTS AS ASSESSED BY TISSUE AND PULSE WAVE DOPPLER ECHOCARDIOGRAPHY
Lindblad YT; Herthelius M; Axelsson J; Vavilis G; Balzano R; Barany P
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:154
High sensitive troponin T and I levels and variation over three months in prevalent hemodialysis patients
Snaedal S; Barany P; Qureshi AR; Heimburger O; Stenvinkel P; Lowbeer C; Szummer K
Review: LAKARTIDNINGEN. 2014;111(27-28):1176-1179
[Phosphate additives in food a potential public health risk. High phosphate levels can lead to cardiovascular disease].
Stenvinkel P; Irving GF; Wegener S; Eyre S; Rippe B; Segelmark M; Barany P; Samuelsson O
Review: DRUGS & AGING. 2014;31(7):493-499
The Use of Estimated Glomerular Filtration Rate for Dose Adjustment of Medications in the Elderly
Elinder C-G; Barany P; Heimburger O
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:410
THYROID HORMONES ASSOCIATE WITH PENTOSIDINE IN HEMODIALYSIS (HD) PATIENTS
Leurs P; Meuwese C; Carrero JJ; Qureshi AR; Anderstam B; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:413
INCREASED LEVELS AND VARIATION OF IL6 IN HEMODIALYSIS VERSUS PERITONEAL DIALYSIS PATIENTS
Snaedal S; Qureshi AR; Carrero JJ; Heimburger O; Stenvinkel P; Barany P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:411
ARTERIAL STIFFNESS AND SKIN AUTOFLUORESCENCE IN END-STAGE RENAL DISEASE (ESRD) PATIENTS
Svedberg O; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Leurs P; Isoyama N; Lindholm B; Anderstam B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:407
CIRCULATING S100A12 (EN-RAGE), SOLUBLE RAGE, AND MORTALITY IN CHRONIC KIDNEY DISEASE STAGE 5 PATIENTS
Isoyama N; Leurs P; Qureshi AR; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Other: NATURE REVIEWS NEPHROLOGY. 2013;9(12):707-708
CHRONIC KIDNEY DISEASE Obesity in children with end-stage renal disease
Krmar RT; Barany P
Conference publication: THERAPEUTIC DRUG MONITORING. 2013;35(5):667-668
Systematic Conversion to Generic Tacrolimus in Stable Kidney Transplant Patients
Rosenborg S; Nordstrom A; Almquist T; Wennberg L; Barany P
Letter: LAKARTIDNINGEN. 2013;110(34-35):1481-1483
[Treatment with cinacalcet in secondary hyperparathyroidism for dialysis patients: The will is good--but what about the evidence?].
Bárány P; Elinder C-G; Samuelsson O
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28:243
DELTA-HE - A NOVEL MARKER OF ERYTHROPOIESIS AND INFLAMMATION - PREDICTS MORTALITY IN PERITONEAL DIALYSIS (PD) PATIENTS
Danielson K; Qureshi AR; Heimburger O; Stenvinkel P; Lindholm B; Hylander-Rossner B; Germanis G; Hansson M; Beshara S; Barany P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28:35
NON-THYROIDAL ILLNESS - A NOVEL RISK FACTOR FOR CORONARY CALCIFICATION AND ARTERIAL STIFFNESS IN DIALYSIS PATIENTS?
Meuwese CL; Carrero JJ; Cabezas-Rodriguez I; Heimburger O; Barany P; Lindholm B; Qureshi AR; Ripsweden J; Dekker FW; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28:217
PREDICTING ARTERIAL STIFFNESS USING SKIN AUTOFLUORESCENCE IN PERITONEAL DIALYSIS PATIENTS
Svedberg O; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Leurs P; Anderstam B
Letter: JOURNAL OF NEUROSURGERY. 2013;118(4):908-912
Barany and traumatic brain injury
Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2012;27(9):1724
EARLY DETECTION OF LEFT VENTRICULAR DYSFUNCTION BY TISSUE DOPPLER ECHOCARDIOGRAPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
Lindblad YT; Axelsson J; Balzano R; Vavilis G; Celsi G; Chromek M; Barany P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27:287
ESSENTIAL POLYUNSATURATED FATTY ACIDS, INFLAMMATION AND MORTALITY IN DIALYSIS PATIENTS
Huang X; Stenvinkel P; Qureshi AR; Riserus U; Cederholm T; Barany P; Heimburger O; Lindholm B; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27:272
ESTIMATED HEPATIC AND ADIPOSE TISSUE STEAROYL-COA DESATURASE-1 ACTIVITIES ARE ASSOCIATED WITH INFLAMMATION AND ALL-CAUSE MORTALITY IN DIALYSIS PATIENTS
Huang X; Stenvinkel P; Qureshi AR; Riserus U; Cederholm T; Barany P; Heimburger O; Lindholm B; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27:410
INSULIN GROWTH FACTOR-1 (IGF-1) AS A PREDICTOR OF NUTRITIONAL STATUS AND MORTALITY IN CHRONIC KIDNEY DISEASE (CKD) STAGE 5 PATIENTS
Jia T; Axelsson TG; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR
Letter: CLINICAL NEPHROLOGY. 2012;77(1):85-86
Screening for anti-factor B autoantibody in a patient with acute renal injury due to dense deposit disease
Krmar RT; Skattum L; Barany P; Jozsi M
Published conference paper: CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY. 2012;178:35-39
Hypogonadism in Males with Chronic Kidney Disease: Another Cause of Resistance to Erythropoiesis-Stimulating Agents?
Stenvinkel P; Barany P
Editorial: NATURE REVIEWS NEPHROLOGY. 2011;8(2):72-74
DIALYSIS IN 2011 Can cardiovascular risk in dialysis patients be decreased?
Stenvinkel P; Barany P
Conference publication: APMIS. 2009;117:143
Target for time to treatment initiation may improve management of patients with ANCA-associated vasculitis (AAV)
Barany P; Wendt M; Bruchfeld A
Conference publication: BLOOD PURIFICATION. 2009;28(4):318
Elevated Visfatin/NAMPT Correlates with Anorexia and Reduced Fasting Serum Amino Acids in CKD Patients
Jesus CJ; Witasp A; Lindholm B; Nordfors L; Schalling M; Axelsson J; Stenvinkel P; Qureshi AR; Heimburger O; Barany P; Suliman ME; Anderstam B
Conference publication: BLOOD PURIFICATION. 2008;26(5):436-437
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Carrero JJ; Axelsson J; Heimburger O; Barany P; Lindholm B; Stenvinkel P; Qureshi AR
Conference publication: BLOOD PURIFICATION. 2008;26(5):435
Endogenous testosterone and mortality due to all-causes and cardiovascular disease in men undergoing hemodialysis
Carrero JJ; Qureshi AR; Parini P; Arver S; Lindholm B; Barany P; Heimburger O; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:311
Association between tumor necrosis factor alpha (TNF) gene polymorphism and cardiovascular mortality in end-stage renal disease patients
Kato S; Axelsson J; Qureshi AR; Yusawa Y; Maruyama Y; Barany P; Heimburger O; Schalling M; Stenvinkel P; Lindholm B; Nordfors L
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:141
S-adenosylhomocysteine levels are elevated and associated with cardiovascular disease in chronic kidney disease patients
Valli A; Carrero JJ; Suliman ME; Qureshi AR; Garibotto G; Barany P; Anderstam B; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:140-141
Serum long pentraxin 3 (PTX3) levels predict death in chronic kidney disease (CKD) patients independently of CRP values
Tong M; Carrero JJ; Suliman M; Qureshi AR; Anderstam B; Axelsson J; Heimburger O; Barany P; Stenvinkel P; Alvestrand A; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:74-75
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in CKD stage 5 patients
Carrero JJ; Qureshi AR; Axelsson J; Barany P; Heimburger O; Alvestrand A; Lindholm B; Stenvinkel P
Conference publication: BLOOD PURIFICATION. 2007;25(4):338
Telomere shortening, a new mortality risk factor in dialysis patients.: Associations with inflammatory markers and fetuin-a levels
Carrero JJ; Stenvinkel P; Fellstrom B; Qureshi AR; Lamb K; Heimbuerger O; Barany P; Radhakrishnan K; Lindholm B; Sovery I; Nordfors L; Shiels PG
Conference publication: BLOOD PURIFICATION. 2007;25(4):355
Is α2-Heremans-Schmid glycoprotein/fetuin-A associated with aspects of the metabolic syndrome in patients with chronic kidney disease (CKD)?
Axelsson J; Ketteler M; Heimburger O; Barany P; Lindholm B; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21:441
C-reactive protein variation and comorbidity in prevalent hemodialysis patients
Jonsdottir SS; Barany P; Heimburger O; Qureshi AR; Danielsson A; Fellstrom B; Wikstrom B; Seeberger A; Alvestrand A; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21:408
The osteoclast inhibitor osteoprotegerin is an independent predictor of survival in end-stage renal disease patients starting dialysis
Matsubara K; Anderstam B; Suliman M; Qureshi AR; Axelsson J; Martola L; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21:127
Toll like receptor 4 (TLR4) and tumor necrosis factor(TNF)-α genotypes influence mortality in end-stage renal disease (ESRD) patients
Kato S; Nordfors L; Axelsson J; Qureshi AR; Yuzawa Y; Maruyama Y; Barany P; Heimburger O; Schalling M; Stenvinkel P; Lindholm B
Letter: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;47(2):372
Serum leptin and epoetin sensitivity -: Reply
Axelsson J; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P; Bárány P
Conference publication: BLOOD PURIFICATION. 2006;24(5-6):479
Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 Exon 8 insertion/deletion polymorphism
Axelsson J; Wang X; Nordfors L; Qureshi AR; Avesani C; Barany P; Schalling M; Stenvinkel P; Heimbuerger O; Lindholm B
Review: SEMINARS IN NEPHROLOGY. 2006;26(1):14-19
Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients
Suliman ME; Stenvinkel P; Bárány P; Qureshi AR; Lindholm B
Letter: KIDNEY INTERNATIONAL. 2005;68(6):2916
Serum fetuin-A and aortic calcification in hemodialysis patients -: Reply from the authors
Axelsson J; Bárány P; Heimbürger O; Lindholm B; Nordfors L; Stenvinkel P
Editorial: NATURE CLINICAL PRACTICE NEPHROLOGY. 2005;1(1):12-13
Is the efficacy of epoetin beta in anemic peritoneal dialysis patients maintained with fortnightly doses? Commentary
Bárány P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V312
The ACE intron 16 del/del genotype is associated with mortality and inflammation in ESRD patients
Watanabe M; Nordfors L; Axelsson J; Barany P; Heimbürger O; Qureshi AR; Suliman M; Schalling M; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V130
Oxidative stress is associated with the insertion/deletion polymorphism in exon 8 of the uncoupling protein 2 gene in ESRD patients
Wang X; Stenvinkel P; Nordfors L; Axelsson J; Qureshi AR; Barany P; Schalling M; Diczfalusy U; Heimbürger O; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V84
Factors associated with bone mineral density in CKD patients
Matsubara K; Suliman ME; Qureshi ART; Axelsson J; Anderstam B; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V78
Association between estrogen receptor alpha (ESRA) gene polymorphism and mortality in end-stage renal disease (ESRD) patients starting dialysis therapy
Kato S; Nordfors L; Stenvinkel P; Heimbürger O; Qureshi AR; Axelsson J; Barany P; Schalling M; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V137
Association between change in body composition and insertion/deletion polymorphism of uncoupling protein 2 in dialysis patients
Wang X; Stenvinkel P; Nordfors L; Heimbürger O; Barany P; Qureshi AR; Axelsson J; Schalling M; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V309
Insulin resistance and dyslipidemia in end-stage renal disease (ESRD) patients are influenced by the interleukin-18-137 G to C polymorphism
Honda H; Nordfors L; Qureshi AR; Axelsson J; Schalling M; Sugisaki T; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V99
Bone mineral density is a predictor of survival in ESRD patients
Matsubara K; Suliman ME; Qureshi ART; Axelsson J; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V83-V84
Plasma glutamate is related to the bone status in CKD patients
Suliman ME; Qureshi ART; Anderstam B; Matsubara K; Axelsson J; Divino JC; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY. 2005;10:A289
A FUNCTIONAL POLYMORPHISM IN THE PROMOTER REGION OF THE GENE ENCODING FOR INTERLEUKIN-6 (IL-6) IS ASSOCIATED WITH INCREASED PLASMA LEVELS OF HIGH DENSITY LIPOPROTEIN (HDL) IN PATIENTS WITH END-STAGE RENAL DISEASE (ESRD)
Axelsson J; Heimburger O; Barany P; Lindholm B; Nordfros L; Stenvinkel P
Editorial: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20(1):16-21
Homocysteine in uraemia - a puzzling and conflicting story
Suliman ME; Bárány P; Kalantar-Zadeh K; Lindholm B; Stenvinkel P
Editorial: BLOOD PURIFICATION. 2005;23(3):203-210
Why do dialysis patients develop a heart of stone and bone of china?
Martola L; Barany P; Stenvinkel P
Review: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19:1-47
Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure
Locatelli F; Aljama PA; Bárány P; Canaud B; Carrera F; Eckardt KU; Hörl WH; Macdougall IC; Macleod A; Wiecek A; Cameron S
Editorial: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19(2):288-293
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: where are we now and where do we go from here?
Locatelli F; Aljama P; Barany P; Canaud B; Carrera F; Eckardt KU; Macdougall IC; Macleod A; Hörl WH; Wiecek A; Cameron S
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:529A
Chronic inflammation independently reduces plasma free amino acids (AA) in end-stage renal disease (ESRD) patients (pts).
Suliman ME; Pecoits R; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Ayala ER; Divino JC; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:536A
Associations between circulating inflammatory markers and renal function in elderly subjects.
Pecoits R; Heimburger O; Stenvinkel P; Barany P; Suliman M; Lindholm B; Fehrman-Ekholm I
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:292A
Single nucleotide polymorphisms (SNPs) in genes coding for C-reactive protein (CRP) and interleukin-6 (IL-6) and clinical consequences of inflammation in chronic renal failure (CRF)
Heimburger O; Marchlewska A; Pecoits-Filho R; Lindholm B; Barany P; Jonsson E; Hoff CM; Schalling M; Stenvinkel P; Nordfors L
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:194A
Plasma total homocysteine (tHcy) is low in inflamed end-stage renal disease (ESRD) patients (pts)
Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:531A
Plasma adiponectin and its relations to albuminuria, type of diabetes, body composition, inflammation and genetic variations in the gene encoding adiponectin in ESRD.
Stenvinkel P; Marchlewska A; Pecoits R; Heimburger O; Hoff C; Holmes C; Axelsson J; Barany P; Lindholm B; Nordfors L
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:676A-677A
Change in common carotid intima media thickness (CC IMT), in first year of dialysis therapy, is related to plasma pentosidine content.
Suliman ME; Stenvinkel P; Jogestrand T; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:532A
Plasma total homocysteine (tHcy) is related to plasma free amino acids (AA) in end-stage renal disease (ESRD) patients (pts).
Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:195A
Higher plasma total homocysteine (tHcy) level is associated with better survival in patients (pts) with end-stage renal disease (ESRD)
Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:530A
Relationship between circulating levels of interleukin-6 (IL-6) and fat mass in patients (pts) with end-stage renal disease (ESRD).
Suliman ME; Axelsson J; Heimburger O; Quershi AR; Barany P; Pecoits R; Lindholm B; Stenvinkel P
Published conference paper: KIDNEY INTERNATIONAL, SUPPLEMENT. 2003;63(84):S172-S176
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients
Pecoits R; Stenvinkel P; Marchlewska A; Heimburger O; Bárány P; Hoff CM; Holmes CJ; Suliman M; Lindholm B; Schalling M; Nordfors L
Published conference paper: AMERICAN JOURNAL OF KIDNEY DISEASES. 2003;41(3):S89-S95
Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus
Suliman ME; Stenvinkel P; Bárányi P; Heimbürger O; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:519A
A functional variant in the myeloperoxidase (MPO) gene is associated with cardiovascular disease in end stage renal disease (ESRD) patients
Pecoits R; Marchlewska A; Nordfors L; Heimburger O; Barany P; Hoff C; Stenvinkel P; Lindholm B; Schalling M
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:222A
Impaired respiratory function is associated with malnutrition and inflammation in ESRD patients
Barany P; Pecoits R; Lindholm B; Heimburger O; Stenvinkel P
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:594A
Plasma pentosidine is associated with inflammation but does not predict outcome in renal replacement therapy
Stenvinkel P; Suliman M; Olof H; Barany P; Pecoits R; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:760A
Relationship between changes in plasma total homocysteine (tHcy) and serum albumin following renal replacement therapy (RRT).
Suliman ME; Stenvinkel P; Barany P; Heimburger O; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:519A-520A
Genetic variation in the gene encoding adiponectin is associated with cardiovascular disease (CVD) and inflammation in end stage renal disease (ESRD) patients
Pecoits R; Stenvinkel P; Marchlewska A; Nordfors L; Heimburger O; Hoff C; Barany P; Lindholm B; Schalling M
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:466A-467A
No association between plasma total homocysteine (tHcy) and common carotid intima thickness (CC IMT) in end-stage renal disease (ESRD) patients (pts)
Suliman ME; Stenvinkel P; Barany P; Heimburger O; Anderstam B; Lindholm B
Published conference paper: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17:32-37
Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure: links to inflammation and oxidative stress
Stenvinkel P; Bárány P
Published conference paper: KIDNEY INTERNATIONAL, SUPPLEMENT. 2002;61(80):103-108
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?
Stenvinkel P; Barany P; Heimbürger O; Pecoits R; Lindholm B
Letter: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(3):528
Accumulation of taurine in patients with renal failure
Suliman ME; Bárány P; Divino JC; Lindholm B; Bergström J
Published conference paper: KIDNEY INTERNATIONAL. 2000;57(4):1727-1735
Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Divino JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2000;72(3):299-300
Physical activity promotes health also among dialysis patients
Stenvinkel P; Elinder CG; Bárány P
Letter: KIDNEY INTERNATIONAL. 1998;53(5):1430-1431
Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure?
Stenvinkel P; Heimbürger O; Lönnqvist F; Bárány P
Book chapter: CRITICAL CARE NEPHROLOGY. 1998;p. 375-389
Nutritional management of the critically ill patient with and without renal failure
Bárány P; Alvestrand A
Published conference paper: MINERAL AND ELECTROLYTE METABOLISM. 1997;23(3-6):273-276
Serum ferritin and tissue iron in anemic dialysis patients
Barany P; Eriksson LC; Hultcrantz R; Pettersson E; Bergstrom J
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1996;7(9):A1117
Physiological effects of correcting anemia in hemodialysis patients (HD pts) to a normal HB
Barany P; Svedenhag J; Katzarski K; Divino J; Norman R; Freyschuss U; Bergstrom J
Review: PERITONEAL DIALYSIS INTERNATIONAL. 1996;16 Suppl 1:S260-S266
Endocrinology and PD: optimal treatment of anemia in peritoneal dialysis patients.
Bárány P
Conference publication: JOURNAL OF CHEMOTHERAPY. 1993;5:605-606
CLOSTRIDIUM-DIFFICILE INFECTION IS A POOR PROGNOSTIC SIGN IN UREMIC PATIENTS
BARANY P; STENVINKEL P; BERGSTROM J; NORD CE
Conference publication: KIDNEY INTERNATIONAL. 1992;41(2):504
LONGITUDINAL-STUDY OF LIFE QUALITY (QL) IN HEMODIALYSIS (HD) PATIENTS TREATED WITH ERYTHROPOIETIN (EPO)
BARANY P; PETTERSSON E
Conference publication: KIDNEY INTERNATIONAL. 1992;41(2):504
LOW-DOSE SUBCUTANEOUS RHUEPO IN RENAL ANEMIA IN CAPD CCPD PATIENTS - INTERIM ANALYSIS OF A SWEDISH MULTICENTER STUDY
BARANY P; CLYNE N; HYLANDER B; JOHANSSON AC; SIMONSEN O; MAGNUSSON M; FRISENETTEFICH C
Conference publication: KIDNEY INTERNATIONAL. 1992;41(2):505
LYMPHOCYTOTOXIC ANTIBODIES AND IMMUNE REACTIVITY INVITRO IN EPO (ERYTHROPOIETIN) TREATED HEMODIALYSIS-PATIENTS
FEHRMAN I; BARANY P; LINDHOLM A
Conference publication: KIDNEY INTERNATIONAL. 1992;41(2):503
CLOSTRIDIUM-DIFFICILE INFECTION (CDI) - A POOR PROGNOSTIC SIGN IN UREMIC PATIENTS
STENVINKEL P; BARANY P; NORD CE; BERGSTROM J
Conference publication: KIDNEY INTERNATIONAL. 1990;37(5):1383
PHYSIOLOGIC EFFECTS OF ERYTHROPOIETIN (EPO) TREATMENT IN ANEMIC HEMODIALYSIS (HD) PATIENTS AT REST AND EXERCISE
BARANY P; FREYSCHUSS U; PETTERSSON E; BERGSTROM J
Visa fler

Anställningar

Klinisk tjänst (timanställd), Njurmedicin, Njurmedicin, Karolinska Universitetssjukhuset, 2024-
Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2024-2027
Klinisk tjänst, ME Högspecialiserad barnmedicin och hemsjukvård, Karolinska Universitetssjukhuset

Examina och utbildning

Docent, njurmedicin, karolinska institutet, 2008

Handledning

Handledning till doktorsexamen
- Joakim Österman, Heart failure, diabetes, and chronic kidney disease prognosis and new treatment opportunities, 2022-
- Ehab Al-Sodany, Renal and cardiovascular outcomes in patients with advanced stage CKD, 2021-
- Kristin Danielson, Iron metabolism in chronic kidney disease, 2018-
- Sunna Snaedal, Markers of inflammation and cardiovascular disease in dialysis patients: variability and prognostic value, 2016
- Ylva Traneus-Lindblad, Early cardiovascular risk markers and cardiac function in children with chronic kidney disease, 2016
- Bodil Sjöberg, Vascular and inflammatory markers in chronic kidney disease, 2015
- Charikleia Chrysostomou
- Jessica Smolander
- Jim Alkas

Redaktör för vetenskaplig tidskrift

CLINICAL KIDNEY JOURNAL, Vetenskaplig redaktör, 2013

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Handledning

Handledning till doktorsexamen

Redaktör för vetenskaplig tidskrift

Nyheter från KI

Kalenderhändelser från KI